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Abstract 
TRANSCRIPTIONAL REGULATION OF THE MEIS2 LOCUS  
Megan Daley Tennant 
 B.S., Bluefield College 
M.S., Appalachian State University 
 
 
Chairperson: Dr. Ted Zerucha 
 
 
The Meis genes are a member of the three-amino acid loop extension (TALE) 
superclass of the homeobox super-family of genes. Homologs of the Meis genes have been 
identified in all animals examined and have been found to be expressed in similar patterns 
during the embryonic development of those animals. The Meis genes code for the production 
of proteins that act as transcription factors. These transcription factors are able to directly 
regulate the expression of target genes but are most well-known for functioning as cofactors, 
directly interacting with other transcription factors and DNA to facilitate transcriptional 
regulation. Most notably, they appear to act as co-factors of the evolutionarily well-
conserved Hox proteins and have also been described to act with other transcription factors 
on DNA. Although the Meis genes are fairly well-characterized in terms of their molecular 
function and expression pattern during development, little is known regarding how their 
expression is regulated. Previously, the Zerucha lab has identified four highly conserved 
noncoding elements associated with the vertebrate Meis2 gene and named them m2de1-4 (for 
Meis2 downstream element). While M2de2-4 have only been found in land vertebrates to 
date, m2de1 is also found in teleosts, including zebrafish, where it is downstream of meis2a. 
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Interestingly, these elements are found within the introns of an adjacent gene, zgc:154061 in 
zebrafish, whose orthologs are always found in an inverted convergently transcribed 
orientation directly downstream of Meis2 in vertebrates. The evolutionarily conserved 
genomic organization of these two genes hints to the sharing of cis-regulatory elements.  
When observing the expression patterns of meis2a and zgc:154061 as well as the 
expression of a reporter transgene directed by m2de1 in zebrafish, there were overlaps in 
expression, specifically around the eye and brain. To determine whether or not m2de1 played 
a role in directing the expression of either of these genes, a portion of m2de1 was excised 
from the zebrafish genome via the CRISPR/Cas9 system. Embryos lacking this portion of 
m2de1 displayed faint meis2a expression in the forebrain and optic tectum but lacked 
expression in the cerebellum and rhombencephalon, as compared to wildtype embryos. When 
observing zgc:154061 expression in mutant fish compared to wildtype, there was no 
difference; however, this could be due to the already low levels of expression of zgc:154061 
and the inability to distinguish any changes in expression to this already low and difficult to 
visualize expression pattern in wildtype embryos. The change in meis2a expression in mutant 
embryos suggests that m2de1 is an important player in directing the expression of meis2a. 
While further testing is needed to identify the transcription factor binding sites that are being 
excised and how this could effect meis2a expression, this project served to further 
characterize m2de1, a highly conserved non-coding element associated with the Meis2 gene. 
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Introduction 
This project serves to gain a better understanding of transcriptional regulation of the 
Meis2 locus. In order to have a better understanding of embryogenesis, it is important to 
understand transcriptional control, specifically how homeobox genes are regulated. While 
both the molecular function and expression patterns of the Meis genes are fairly well 
characterized, little is known regarding how the expression of the Meis genes is regulated 
throughout development. The Zerucha laboratory has identified four highly conserved 
noncoding elements associated with the vertebrate Meis2 gene. These elements were named 
m2de1-4 (for Meis2 downstream element 1-4). While M2de2-4 have only been found in land 
vertebrates to date, m2de1 is also found in teleosts, including zebrafish where it is 
downstream of meis2a. Interestingly, these elements are found within the introns of an 
adjacent gene, zgc:154061 in zebrafish, whose orthologs are always found in an inverted 
convergently transcribed orientation directly downstream of Meis2 in vertebrates. Previous 
studies have shown overlaps in the expression patterns of meis2a and zgc:154061 as well as 
the expression of a reporter transgene directed by m2de1 in zebrafish (Carpenter et al., 2016).  
We propose that the genomic organization of these two genes has been evolutionarily 
conserved due to the sharing of cis-regulatory elements. This project serves to further 
characterize one of the highly conserved elements, m2de1 within this context. Using the 
CRISPR/Cas9 system, zebrafish m2de1 was targeted in order to excise a portion of the 
element in order to determine the effects on the expression of both meis2a and zgc:154061. 
Regulation of transcription is a complex process that controls when, where and how 
often a gene is transcribed. The regulation of gene transcription plays an important role in 
embryogenesis, specifically through directing cell division, differentiation and patterning 
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(Wolpert, 2007).  During development, homeobox genes have been shown to play important 
roles in the context of the regulation of gene expression (Wolpert, 2007).   
Homeobox genes make up a large super-family of genes that are highly conserved 
across species. Originally discovered in Drosophila melanogaster (the common fruit fly), it 
was noted that mutations to these genes caused homeosis, where one body segment of the fly 
takes on the characteristics of another (McGinnis et al, 1984; Morata and Lawrence, 1977). 
Since their discovery in Drosophila, they have been identified in all multicellular eukaryotes 
and over 200 homeobox genes have been identified (“Homeoboxes,” 2012). These genes 
encode transcription factors that regulate downstream target genes (Chariot et al., 1999) and 
are crucial for embryogenesis as they often act at or near the top of genetic hierarchies and 
thus direct expression of suites of downstream developmental genes (Burglin et al. 1997; 
Chang et al., 1996; Chariot et al., 1999; Mukherjee and Burglin, 2007). Homeobox genes 
contain a highly conserved, approximately 180 base pair sequence, known as the homeobox. 
The homeobox of each gene encodes for a specific homeodomain, which comprises 
approximately 60 amino acids (Gehring, 1987; Gehring, 1993; McGinnis et al., 1984). 
Generally, the homeodomain acts as a DNA-binding motif that binds to cis regulatory 
elements. When homeodomain transcription factors bind to cis regulatory elements, they are 
able to control spatial and temporal regulation of the target gene (Blackwood and Kadonaga, 
1998).  
The homeodomain structure consists of a 3 α-helix bundle. Helices one and two form 
a helix-loop-helix structure. The third helix lies perpendicular to the other two helices, 
forming a helix-turn-helix with the second α-helix. The helix-turn-helix structure is what 
allows the homeodomain protein to bind to DNA (Fig. 1) (Banarjee-Basu et al., 2001; 
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Burglin, 1997; Longobardi et al., 2014; Mukherjee and Burglin, 2007; Shang et al., 1994). 
The third α-helix lies in the major groove of the DNA as the numerous amino acids interact 
with both strands of the DNA helix through intermolecular and hydrophobic interactions 
(Dror et al, 2014; Gehring et al., 1994; Lappin et al., 2006). In addition to the interactions 
occurring between the protein and the DNA in the major groove, there are also interactions 
occurring within the minor groove of the DNA. The N-terminal tail of the homeodomain 
protein interacts with the minor groove of the DNA (Dror et al., 2014; Gehring et al., 1994; 
Lappin et al., 2006; Shang et al., 1994) while the C-terminal end forms salt bridges to further 
the interaction between the protein and the DNA (Gehring et al., 1994) 
Figure 1: Schematic of an Antennapedia homeodomain protein interacting with double 
stranded DNA. Alpha helix one and two lie parallel to one another while alpha helix two 
and three are perpendicular to one another. The third alpha helix lies in the groove of the 
double stranded DNA. The N-terminal domain interacts with other transcription factors in 
order to increase stability of the complex, while the C-terminal domain also interacts with 
transcription factors, like Hox. (Based on The Homeobox Page, maintained by Burglin, T. R., 
http://homeobox.biosci.ki.se/) 
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Some homeodomain proteins, such as Hox proteins, play significant roles in the 
anterior and posterior patterning of bilateral animals (Amores et al., 1998; Moens and Selleri, 
2006; Waskiewicz et al., 2001). The Hox genes are well conserved in sequence and function 
across species. While different animal species have varying numbers of Hox genes, they have 
been identified in all species tested thus far (Lemons and McGinnis, 2006). Hox genes are 
normally found in clusters, with teleosts having seven clusters, tetrapods having four Hox 
clusters and Drosophilia having one cluster (Amores et al., 1998; Krumlauf, 1994; Lappin et 
al., 2006; Lemons and McGinnis, 2006). The order and location of the Hox genes within a 
cluster on a chromosome correlate to the anterior posterior expression and timing of 
expression of these genes. For example, Hox genes that are positioned nearer the 3’ end tend 
to be expressed earlier in development and more towards the anterior (head) region of the 
developing embryo as compared to genes on the 5’ end. Likewise, the Hox genes that are 
expressed later in development and more toward the posterior (tail) area of the embryo, are 
located closer to the 5’ end (Amores et al, 1998; McGinnis and Krumlauf, 1992). This 
specific organization that is observed for Hox genes assists in both spatial and temporal 
regulation of gene specific expression and is referred to as collinearity (Amores et al., 1998; 
McGinnis and Krumlauf, 1992; Prince et al., 1998). Interestingly, the disruption of Hox 
genes that alter their spatial and temporal expression can result in homeotic transformations 
(Amores et al., 1998; Lemons and McGinnis, 2006; Noordermeer et al., 2011). For example, 
in Drosphila, a mutation that expands the anterior expression of the Antp Hox gene results in 
a fly developing a leg where an antenna should develop (McGinnis et al., 1984).  
As previously discussed, homeodomain proteins, including members of the Hox 
family, function by binding DNA to direct the transcription of target genes. Often, 
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homeodomain proteins, including Hox, bind to TAAT nucleotide sequences within the major 
groove of the DNA sequence (Burglin, 1997). This implies these proteins bind DNA with 
relatively low specificity since many of them recognize this same core sequence. In addition 
to binding with low specificity, studies in D. melanogaster have shown that homeodomain 
proteins typically bind DNA with relatively low affinity (Crocker et al., 2015). This low 
specificity and low affinity of homeodomain binding is difficult to reconcile with the 
important and specific roles they play during development. In order to increase binding 
affinity and increase binding specificity, homeodomain proteins often interact with other 
proteins to form complexes. These protein complexes can contain multiple homeodomain 
proteins, acting as cofactors, and are able to increase binding specificity by increasing the 
number of binding sites that they occupy. In addition, multiple proteins binding DNA as a 
complex will also increase the affinity of the binding. This increase in affinity and specificity 
helps to better regulate the complex process of gene transcription (Mann and Affolter, 1998; 
Moens and Selleri, 2006).  
There are many homeodomain proteins that act as cofactors. One group of cofactors 
belongs to the Three Amino Acid Loop Extension (TALE) class of homeodomain proteins. 
The TALE class of homeodomain proteins contains three additional amino acids between 
alpha helices one and two of the homeodomain. In animals, including vertebrates, gene 
families in the TALE class include Meis, Pbc, Tgif and Iro (Burglin, 1997; Longobardi et al., 
2014; Mukherjee and Burglin, 2007). TALE genes have also been identified in fungi and 
plants (Burglin, 1997). Such cofactors have the ability to bind to one another as well as other 
homeodomain proteins while also binding to DNA at cis regulatory elements. This allows for 
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the formation of protein complexes, containing multiple transcriptional proteins and DNA 
(Mann and Affolter, 1998). 
TALE proteins, such as Meis and Pbx, often interact with Hox proteins in binding 
DNA and controlling gene transcription (Choe et al., 2014). Not only do these proteins bind 
to DNA, they also have the ability to bind to one another, through structures within their N-
terminal and C-terminal domains. The C-terminal region interacts with the N-terminal region 
of the Hox protein (Chang et al.,1997). As mentioned previously, Hox commonly interacts 
with a TAAT binding sequence, resulting in low binding specificity. However, in mice, when 
Hox interacts with the Pbx cofactor, the two proteins bind DNA at a TGATTGAT sequence. 
Similar changes are seen in other models (Waskiewicz et al., 2001). This increases the 
binding specificity of Hox, ultimately helping to regulate gene transcription with greater 
specificity. 
In addition to working in conjunction with Hox proteins, sequences of the N-terminal 
domain of Pbx proteins allow them to bind to the Meis cofactor (Chang et al., 1997; Choe et 
al., 2002; Jacobs et al., 1999). This specific dimer forms on TGATTGACAG sequences, with 
Pbx bound to the TGAT sequence and Meis bound to the remaining, unbound nucleotides. 
Interestingly, Meis and Pbx will form dimers even when the specific binding sequence for 
Meis is not present; this indicates that Meis and Pbx have a high affinity for each other 
(Chang et al., 1997). Some of the Hox proteins can also use their N-terminal domain to 
interact with the C-terminal domain of Meis proteins, though the Hox-Meis dimer is not 
common as only a few of the different Hox proteins have the ability to interact directly with 
Meis (Shen et al., 1997).  
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In addition to these dimers, Meis, Pbx and Hox can also form trimers (Chang et al., 
1997; Waskiewicz et al., 2001). The Pbx-Meis-Hox trimers are composed of a Meis protein 
binding to its specific DNA sequence while also interacting with a Pbx-Hox dimer (Chang et 
al., 1997; Jacobs et al., 1999). The trimer is formed when Hox binds Pbx via the Hox N-
terminal domain and Pbx binds Meis through their N-terminal domains (Fig. 2) (Choe at al., 
2002; Knoepfler and Kamps, 1995; Shanmugam et al., 1999). Both trimers and dimers have 
been found to bind in the absence of DNA, indicating that these proteins have a high affinity 
for each other that is DNA independent (Chang et al., 1997; Shen et al., 1999). Furthermore, 
the incorporation of the Meis cofactor to form trimers rather than dimers, has been shown to 
increase the stability and function of transcriptional control (Jacobs et al., 1999). 
 
 
Figure 2: A schematic diagram of Meis, Pbx and Hox proteins working together as 
transcription factors. Each protein binds to a specific sequence on the black strand of DNA 
while also working together to form a trimer. The trimer is formed when the N-terminal 
domain of the Meis protein attaches to the N-terminal domain of the Pbx protein. At the same 
time, the N-terminal domain of the Hox protein is also interacting with Pbx. The resulting 
conformation acts as a trimer to either activate or repress target genes. The Meis protein is 
shown in pink, the Pbx protein is shown in orange and the Hox protein in shown in green. 
The target gene is shown in blue and the direction of transcription is indicated by the arrow.  
 
While homeodomain proteins can work together as dimers and trimers to increase 
binding specificity, some homeobox genes like PBC, MEIS and KNOX are known to use 
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alternative splicing events outside of the conserved regions to generate variations within the 
C-termini (Burglin, 1997; Longobardi et al., 2014; Tamaoki et al., 1995). These variations 
within the C-terminal tails are believed to slightly alter the binding specificity allowing the 
protein to bind to slightly different DNA sequences (Tamaoki et al., 2015). These alternative 
splicing events can lead to different homeodomain products being generated using the same 
promotor.  
The interactions of transcription factors acting upon cis regulatory elements play a 
significant role in organismal development. More specifically, homeodomain proteins acting 
as transcription factors play a crucial role in spatial and temporal gene regulation during 
embryogenesis. These interactions allow for complex anatomical systems to develop in a 
precise, tightly controlled manner. While the role of individual homeodomain proteins, like 
the Hox family, in development is relatively well understood, there are still many 
unanswered questions concerning how they act as complexes. In order to gain a better insight 
into the complex molecular interactions occurring during development, it is important to gain 
a better understanding of the cofactors, such as the Meis genes, that facilitate the optimal 
function of these proteins.  
The Meis genes were first discovered in a study of mouse myeloid ecotropic leukemia 
virus. It was found that the mouse leukemia virus integrated into a specific site that was later 
identified as a gene. Because of this, the gene was named the myeloid ecotropic leukemia 
virus integration site (Meis) (Moskow et al., 1995). Paralogs of the gene were subsequently 
identified and this led to the establishment of the Meis gene family. Drosophila have a single 
member of the Meis family, homothorax (hth) (Kurant et al., 1998; Pai et al., 1998). 
Tetrapods have at least three Meis genes, Meis1, Meis2, and Meis3 (Moskow et al., 1995; 
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Nakamura et al., 1996; Waskiewicz et al., 2001). Tetrapods also have two related Meis genes, 
Prep1 and Prep2 (Berthelsen et al., 1998). However, a genome duplication event occurred 
following the divergence of the teleost lineage from the lineage that would give rise to 
tetrapods. This resulted in ohnologs in teleosts of the Meis1 and Meis2 genes: meis1a, 
meis1b, meis2a and meis2b (Amores et al., 1998). To date, Meis gene(s) have been identified 
in all vertebrates examined (Table 1), while Knox genes in plants show very similar sequence 
identity to the Meis genes. The similarities between the Meis and Prep gene families suggest 
that they diverged from a common ancestor (Burglin, 1997).   
Table 1: Species and common name of vertebrates with Meis genes, including resources 
for each species listed.  
Species Common name Resource(s) 
Danio rerio  Zebrafish (Choe et al., 2002; Sagerstrom et al., 2001; 
Waskiewicz et al., 2001; Zerucha and Prince, 
2001) 
Xenopus Frog (Salzberg et al., 1999; Steelman et al., 1997) 
Gallus gallus Chicken (Coy and Borycki, 2010) 
Mus musculus Mouse (Cecconi et al., 1997; Moskow et al., 1995; 
Nakamura et al., 1996) 
Homo sapiens Human (Smith et al., 1997; Steelman et al., 1997) 
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Like many homeodomain proteins, the homeodomains across the Meis family are 
highly conserved, with a preferred binding sequence of TAAT, causing Meis to bind 
sequences with poor affinity and low specificity (Moens and Prince, 2001; Waskiewicz et al., 
2001). However, when Meis forms a transcription factor complex by interacting with 
cofactors such as Pbx and Hox, binding specificity is increased (Moens and Prince, 2002; 
Waskiewicz et al., 2001). As mentioned on pages 6 and 8, Meis proteins act as cofactors, 
binding both transcription factors and regions of DNA known as cis-regulatory sequences. In 
order for Meis proteins to carry out these functions, the homeodomain and N-terminal 
domain must carry out specific roles (Burglin, 1997; Chang et al., 1997; Jacobs et al., 1999; 
Shanmugam et al., 1999). The homeodomain is the structure that the Meis protein uses to 
bind DNA (Chang et al., 1997). Alone, the interaction between the Meis homeodomain and 
DNA has been determined to be rather weak (Burglin, 1997). The N-terminal domain 
functions to increase the strength of the interactions. This is the region of the protein that 
enables Meis to interact with other transcriptional proteins, or cofactors, ultimately 
increasing stability and specificity when binding DNA as a complex (Chang et al, 1997; 
Choe et al., 2002; Jacobs et al., 1999; Shanmugam et al., 1999). The C-terminal region of 
Meis proteins has also been shown to interact with numerous Hox proteins (Fig. 1) (Shen et 
al., 1997; Williams et al., 2005). The C-terminal domain has also been shown to accelerate 
the progression of Acute Myelogenous Leukemia when Hoxa9 and Meis transactivate genes 
that lead to cancer cell proliferation (Mamo et al., 2006).  
One way in which Meis proteins function during development is by forming a 
transcription factor complex with Pbx and Hox, as previously mentioned. The transcription 
factor complex then binds cis-regulatory elements (Moens and Prince, 2002; Waskiewicz et 
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al., 2001). When this complex is formed, it has a different preferred binding sequence as 
compared to the non-specific binding sequences of the individual proteins. Together Meis 
and Pbx bind a TGATTGAC sequence, with Pbx binding to the TGAT sequence and Meis 
binding the TGAC sequence (Knoepfler et al., 1999). As the binding specificity and stability 
increase when Meis and Pbx act together as cofactors, the same is true for when the they act 
as cofactors with the homeodomain protein Hox (Choe et al., 2002; Knoepfler et al., 1999; 
Moens and Prince, 2002; Waskiewiez et al., 2001). In addition to working as cofactors with 
Hox and Pbx, Meis also works with a number of other genes during development. 
Since the identification of the Meis genes in the myeloid ecotopic leukemia virus, it 
has been shown that an overexpression of Meis1 causes blood cancer, or leukemia, in both 
mice and humans (Hisa et al., 2004, Moskow et al., 1995). Leukemia cells with high levels of 
Meis1 have slower apoptotic pathways (Grubach et al., 2008). It has been proposed that viral 
integrations in Meis1 result in a dysregulation of the Meis1 protein, which leads to the 
inability to differentiate. This can also result in an increase in proliferation of developing 
myeloid cells. This mutation affecting differentiation leads to the formation of the myeloid 
leukemia (Moskow et al., 1995).  
It has also been suggested that the inability of the Meis/ Pbx complex to regulate Hox 
can lead to cancer development and increased malignancy. This is due to Hox’s role in 
differentiation and apoptosis (Grubach et al., 2008). Studies have also shown that forced co-
expression of Hoxa9 and Meis1 in murine marrow leads to the rapid development of 
leukemia. Using this information, human leukemic cell lines were tested for co-expression of 
HOXA9 and MEIS1 and results showed that co-activation of the two genes is exclusive to 
acute myelogenous leukemia and is common in such cases (Lawerence et al., 1999). In 
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addition, Hoxa9, Hoxa7 and Meis1 proteins are found to be co-localization in leukemia cell 
lines in both mouse and human. This suggests that while Meis1 is a common site for 
retroviral insertions, both Meis and Hox genes could operate together to cause myeloid 
leukemia (Lawerence et al., 1999; Nakamura et al., 1996).  
As mentioned on page 8, there are three members of the Meis gene family. Meis1 
works with proteins such as HoxA9, HoxB3, Pbx1 and Prep1 (Berkes et al., 2004; Cvejic et 
al., 2011; Hisa et al., 2004; Melvin et al., 2013; Thorsteinsdottir et al., 2001). Meis1 has been 
studied in many different vertebrate embryos. Meis1 is expressed during the early and later 
stages of embryogenesis. During the early stages of development, Meis1 is expressed in the 
posterior regions of the embryo, specifically in the primitive streak, somites and mesoderm 
(Coy and Boryicki, 2010; Maeda et al., 2002). Meis1 also plays an important role in 
hematopoiesis, as well as heart, muscle and eye development in numerous species, including 
zebrafish, mice and human (Berkes et al., 2004; Cvejic et al., 2011; Hisa et al., 2004; Melvin 
et al., 2013; Thorsteinsdottir et al., 2001). The expression of Meis1 has also been observed in 
the developing limbs and branchial arches of chick (Coy and Borycki, 2010), xenopus 
(Maeda et al., 2002) and zebrafish (Waskiewicz et al., 2001).  
In mice, Meis1 expression has been seen in the developing eye and brain (Bessa et al., 
2008; Hisa et al., 2004; Toresson et al., 2000). Specifically, Meis1 has been observed around 
the retina (Bessa et al., 2008; Hisa et al., 2004) in a similar pattern to that of Pax6 (Zhang et 
al., 2002). Meis1 has been shown to bind an enhancer for Pax6 that controls eye 
development, suggesting that Pax6 expression is Meis1 dependent (Zhang et al., 2002). Mice 
lacking proper Meis1 function develop smaller lenses and partially duplicated retinas as 
compared to wild type mice (Hisa et al., 2004). Meis1 expression has also been observed in 
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low levels in the telencephalon of embryonic day 10.5 mouse embryos, around the 
ventricular zone. The telencephalon ultimately forms the cerebrum of the brain (Toresson et 
al., 2000). In addition to the expression seen in the eyes and brain area, Meis1 also plays a 
role in limb development where expression has been observed proximal to the site of limb 
bud development, being driven by the signaling molecule retinoic acid (Mercader et al., 
2000). In previous studies, Meis1 mutant mice have developed malformed capillaries and 
suffered from hemorrhaging, ultimately dying by embryonic day 14.5 (Hisa et al., 2004; 
Nakamura, 2005).  
Due to a genome duplication, teleosts originally had two Meis1 genes: meis1a and 
meis1b (Amores et al., 1998). Over time, it appeared as if the meis1a gene was lost in 
teleosts, likely due to a loss of coding exons (Irimia et al., 2011). However, recent 
annotations show that not all teleosts have lost the meis1a gene. For example, zebrafish, a 
member of the teleost family, originally had a gene identified as meis4, and recent 
annotations show that meis4 in zebrafish is indeed a second meis1 gene, meis1a. This 
indicates that zebrafish still have two meis1 genes, yet the meis1a gene has yet to be 
characterized (Waskiewicz et al., 2001). The second meis1 gene, meis1b, is expressed 
throughout the developing face and hindbrain of zebrafish and also plays a role in 
hematopoiesis (Cvejic et al., 2011; Melvin et al., 2013). Similar to the previously mentioned 
mice studies, studies in zebrafish have shown that when meis1b is knocked down, embryos 
suffered hematopoiesis defects and poor vascularization (Amali et al., 2013). 
Much like Meis1, Meis2 shows similarities in expression patterns across model 
organisms, such as mouse, zebrafish and chicken. Meis2 is expressed in the developing brain, 
eye, branchial arches, spinal cord, heart and limbs (Bumsted-O’Brien et al., 2007; Cecconi et 
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al., 1997; Coy and Borycki, 2010; Mercader et al., 2005; Oulad-Abdelghani et al., 1997; 
Waskiewicz et al., 2010). During mouse embryonic development, Meis2 is expressed in the 
somitic compartment and related areas, such as lateral muscle tissue. As development 
continues, the protein can be found in the mesoderm around embryonic day 8 (E8). By E10, 
it can be observed in the developing forebrain, hindbrain and spinal cord (Cecconi et al., 
1997). The hindbrain activity of Meis2 is partially regulated by polycomb proteins. These 
proteins bind to a repressor element near the Meis2 gene. When the gene is expressed, an 
enhancer loop, specific to the midbrain, loops around the repressor, ultimately removing the 
repressor protein and activating the expression of Meis2 (Kondo et al., 2013). Similar to the 
expression of Meis1, Meis2 is active in the developing brain at high levels. In E10.5 mice 
embryos, Meis2 is found in high levels under the ventricular zone. The highest concentration 
of the Meis2 protein is found in the subventricular zone and the mantel regions of the 
telencephalon (Toresson et al., 2000).  
The expression of Meis2 overlaps significantly with Pax6 in the eye. Meis2 binds to 
an enhancer element of Pax6 and drives the expression of the gene. This results in decreased 
levels of Pax6 when Meis2 is decreased and higher levels of Pax6 when Meis2 is increased 
(Zhang et al., 2002). Together, the two proteins have been shown to play a role in the 
development of the olfactory bulb in mice (Agoston et al., 2014). 
Meis2 has also been shown to play a role in the development of limbs in vertebrates 
(Capdevilla et al., 1999). Retinoic acid activates the transcription of Meis2 and this helps to 
ensure proper expression in the proximal end of developing limbs. When Meis2 is not 
expressed properly, it results in loss of digits and limb defects in chickens (Capdevila et al., 
1999; Mercader et al., 2000). Meis2 is expressed in low levels in the developing forelimbs 
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and hindlimbs of E15 mouse embryos. However, in bats, Meis2 is highly expressed in the 
interdigital tissues between the digits. This suggests that Meis2 plays a role in the sculpting 
of the wing. Further, it is suggested that Meis2 plays a role in the retention of interdigital 
tissue between the digits in bats, ultimately forming the webbing of the bat wing. The low 
levels of Meis2 in developing mice limbs, as compared to, the high levels seen in the 
developing bat wing suggests that mice may not have sufficient Meis2 expression to form 
interdigital tissue. Conversely, the higher levels of Meis2 in the developing bat wing suggests 
that the high expression is enough to retain the interdigital tissues between the digits of a bat 
(Dai et al., 2014).  
Meis2 has also been shown to play a role in craniofacial development. A study from 
2013 showed that 7 of 9 people lacking a functional copy of MEIS2 possessed some level of 
cleft palate. This suggests that MEIS2 is important for closure of the palate in humans. Of 
these individuals lacking a functional copy of MEIS2, all individuals possessed some form of 
a learning disability, with the worst being a mild intellectual disability. Lastly, this study 
showed that MEIS2 deficient individuals also possessed other craniofacial deformities 
besides cleft palate. While these were only mild defects, typically resulting in overlapping 
facial features such as a wide forehead or shortened philtrum, it is an interesting finding 
(Johansson et al., 2013).    
In zebrafish, the genome duplication event that occurred in teleosts, following the 
divergence from the tetrapod lineage, resulted in two functional Meis2 genes, meis2a and 
meis2b (Biemar et al., 2001; Waskiewicz et al., 2001; Zerucha and Prince, 2001). In 
zebrafish, meis2b is expressed during the first part of gastrulation (Biemar et al., 2001; 
Zerucha and Prince, 2001). Later during development, expression is observed in the central 
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nervous system, the developing eye, the forebrain, midbrain and hindbrain, spinal cord and 
the lateral mesoderm (Bessa et al., 2008; Biemar et al., 2001; Moens and Prince, 2002). 
Specifically, meis2b is expressed throughout the hindbrain. The expression within the 
hindbrain spreads throughout development, and by 12 hours post fertilization (hpf), 
expression is observed in the forebrain, midbrain and hindbrain. Expression of meis2b is also 
observed in the anterior boundaries of the somites after segmentation has occurred. However, 
by 14 hpf, expression appears to be down-regulated. Expression of meis2b also appears in the 
retina of developing zebrafish around 36 hpf (Zerucha and Prince, 2001). The expression of 
meis2a is similar to the expression of meis2b; however, meis2a is also seen in the developing 
branchial arches and limb buds (Coy and Borycki, 2010; Mercader et al., 1999; Waskiewicz 
et al., 2001) The overlapping expression pattern of meis2a and meis2b in zebrafish is similar 
to the expression pattern of Meis2 observed in mice (Santos et al., 2010; Zerucha and Prince, 
2001).  
The third member of the Meis family, Meis3 also shows similar expression patterns 
between species. Much like Meis1 and Meis2, Meis3 was originally duplicated in teleosts. 
However, it appears as if the second Meis3 gene (meis3.2) in zebrafish has been subsequently 
lost since the genome duplication event (Waskiewicz et al., 201). The remaining meis3 gene 
is first seen observed in the developing hindbrain of zebrafish and Xenopus (Choe et al., 
2002; Sagerstrom et al., 2001; Salzberg et al, 1999; Waskiewicz et al, 2001). Later during 
development, zebrafish meis3 is observed in the somites, pectoral fin and neural tube 
(Sagerstrom et al., 2001; Waskiewicz et al., 2001). Meis3 is also active in the developing 
pancreas of mice and zebrafish, as it plays a role in insulin beta-cell survival (Liu et al., 
2010). Meis3 has also been observed to play an important role in posterior neural 
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development in Xenopus (Salzberg et al., 1999). In zebrafish, meis3 can change the fate of 
midbrain and forebrain cells into hindbrain cells (Vlachakis et al., 2001).  In loss of function 
studies of Meis3, posterior neural tissues in the hindbrain were disturbed (Choe et al., 2002; 
Dibner et al., 2001). This demonstrates the importance of Meis3 in the developing hindbrain.   
It is clear that Meis genes play an important role during embryonic development 
across species. Though there are differences within each individual Meis gene’s expression 
patterns, it is apparent that they share developmental roles. Structurally, all Meis proteins 
have homeodomains; functionally, all Meis proteins bind DNA and regulate gene 
transcription during embryonic development and the coding regions of the genes are 
conserved across species (Irimia et al., 2011). While the basic molecular function and 
expression patterns of Meis are known, it is unknown what is actually controlling these genes 
during transcription. In order to have a better understanding of how the Meis genes are 
regulated, cis-regulatory elements that direct their expression must be identified (Fisher et al., 
2006; Hughes et al., 2005). To do this, phylogenetic footprinting can be used to locate highly 
conserved non-coding elements (HCNEs) near the Meis genes. HCNEs have been shown to 
often act as cis-regulatory elements (Fisher et al., 2006; Hughes et al. 2005, Woolfe et al., 
2005). Once potential cis- regulatory elements have been identified, they can be tested in 
order to confirm whether or not they are able to regulate the transcription of Meis genes. 
Previously, four HCNEs that possibly are cis-regulatory elements associated with the 
Meis2 gene (meis2a in zebrafish) were identified by Zerucha and Wellington (unpublished 
data). Currently, the Zerucha lab is focusing on characterizing these elements to determine if 
they are functioning as cis-regulatory elements and regulating the function of Meis2a. One of 
the elements has also been described by Parker et al. (2011). Work by both Parker et al. 
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(2011) and the Zerucha lab (unpublished) have shown that the 3288 element (Parker et al., 
2011) and m2de1 (Zerucha lab, unpublished data) overlap in nucleotide sequence and 
genomic location. In addition, they direct expression of reporter transgenes in a pattern 
broadly similar to a subset of known Meis2 expression in the midbrain and hindbrain in 
zebrafish, while the 3288 element also shows similar expression patterns in lampreys (Parker 
et al., 2011; Parker et al., 2014). The m2de1 element also directs expression to muscle fibers 
throughout the trunk of the developing zebrafish embryo later in development (Zerucha lab, 
unpublished data). After further examination, the 3288 element is 17 basepairs shorter than 
m2de1 on the 5’ end and 19 basepair shorter on the 3’ end, implying that 3288 may only be a 
fragment of the entire m2de1 element. This is likely the cause of the discrepancy between 
expression patterns between 3288 and m2de1 (Zerucha lab, unpublished data). Both m2de1 
and 3288 have binding sites for the Pbx-Hox dimer, an important transcription factor 
complex for the Meis proteins (Parker et al., 2011). 
The identification and characterization of these elements reveals that potential cis-
regulatory elements can be identified through phylogenetic footprinting, which makes use of 
the conserved nature of cis-regulatory elements and compares non-coding genomic 
sequences across multiple species associated in order to identify Highly Conserved 
Noncoding Elements (HCNEs) (Kikuta et al., 2007, Muller et al., 2002; Santini et al., 2003; 
Woolfe et al., 2005). This offers a starting point in de-coding regulatory elements that play a 
role in the development of vertebrates (Parker et al., 2011). The data from both zebrafish and 
lamprey show that ancient conserved enhancer sequences are suggestive of conserved 
developmental mechanisms across vertebrates (Parker et al., 2014). By better understanding 
the regulatory mechanisms associated with the Meis family, further insight will be gained 
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into the developmental process. Furthermore, understanding the regulatory mechanisms 
associated with Meis genes will also give insight into cell proliferation and the effect on 
cancers, such as leukemia.  
While observing the expression directed by m2de1 can give great insight into the 
characterization of the element, other experiments are also needed to further characterize the 
element. The Zerucha lab has previously shown that the expression directed by m2de1 is 
similar to the expression pattern of meis2a in developing zebrafish embryos. This suggests 
that m2de1 is acting as an enhancer and directing the expression of meis2a. In order to better 
understand the relationship between meis2a and m2de1 in zebrafish, m2de1 can be knocked 
out by using genome engineering, such as the CRISPR/Cas9 system. The expression patterns 
of meis2a can then be observed both before and after the knockout of the element to 
determine whether or not m2de1 plays a role in the regulatory mechanisms associated with 
meis2a.  
Genome engineering is a broad term referring to the techniques and mechanisms 
established to generate targeted modifications within the genetic information, or the genome, 
of living organisms. In the past, genetic engineers have been able to insert and delete genes in 
a variety of organisms; however, these insertions and deletions were not precise, as their 
location could be difficult to specify (Pennisi, 2013). In recent years, genome editing tools 
have improved.  Zinc Finger Nucleases (ZFNs) and truncated Transcription Activator-Like 
Effector Nucleases (TALENs) are genome editing tools that induce double stranded breaks at 
desired loci. These breaks can be repaired by error prone non-homologous end joining, 
ultimately generating small insertions or deletions at the cut sites (Wood et al., 2011). With 
ZFNs and TALENs, both technologies require custom designed proteins for each DNA 
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target; however, designing custom proteins is both expensive, time consuming and difficult 
to engineer. Although both technologies have begun to enable targeted genome 
modifications, there is still a need for genome editing technology that is easy to engineer, 
affordable and easily scalable (Cong et al., 2013).  
While TALENs and ZFNs continue to be used and improved in the world of genetic 
engineering, a new system was identified in which Cas9 (CRISPR associated protein 9) 
nucleases are directed by short RNAs to induce precise cleavage at desired endogenous loci 
(Cong et al., 2013). The Clustered Regularly Interspaced Short Palindromic Repeats 
(CRISPR) system was first identified in bacteria in 1987 when Nakata and colleagues 
observed a repetitive sequence at the end of a gene in Escherichia coli (Ishino et al., 1987). 
While the full implications of these repeat sequences were not clear at first, in 2005, 
bioinformatics groups were able to match the spacing between these repetitive sequences to 
the sequences of phages (Mojica et al., 2000; Pourcel et al., 2005).  
Bacteria, as well as archaea, have adaptive immune defenses against plasmids and 
viruses that use short RNA fragments to direct the degradation of foreign nucleic acids (Jinek 
et al., 2012; Mali et al., 2013). It was found that when CRISPR acts against invading phages, 
bacteria transcribe spacer DNA and palindromic DNA into a single RNA molecule. The cell 
then cuts this single molecule into short CRISPR RNAs (crRNAs) which act with trans-
activating RNAs (tracrRNAs) and Cas9 proteins to attack foreign DNA that matches the 
sequence of the crRNA (Deltcheva et al., 2011).  
To better understand the mechanisms associated with this newly identified CRISPR 
system, a study was performed in Streptococcus pyogenes type II. Here, the CRISPR system 
showed that a CRISPR RNA (crRNA) fused to a trans-activating crRNA (tracrRNA) to form 
21 
 
a two RNA structure. The structure proved sufficient to direct the CRISPR associated Cas9 
protein to a specific DNA sequence, cleaving the target site and ultimately generating a 
double stranded break (Jinek et al., 2012). The mechanisms observed in S. pyogenes 
suggested that the CRISPR system might function in eukaryotic organisms. By using RNA 
sequences to cleave target genomic sites, a system like CRISPR could improve the current 
field of genetic engineering (Mali et al., 2013). 
 Effective genome editing requires that sequences are targeted with both precision and 
efficiency (Cong et al., 2013). In order to observe the efficiency of the CRISPR/ Cas9 
system, a stable cell line containing a GFP coding sequence disrupted by a stop codon was 
established. Due to the stop codon, the protein fragment did not fluoresce. Next, crRNA and 
tracrRNA molecules were fused together to generate a single guide RNA (gRNA). Two 
separate gRNAs were designed to target the fragment containing the disrupted GFP 
sequence. If the gRNAs were able to delete the stop codon within the GFP sequence, the 
protein would be able to fluoresce (Mali et al., 2013). The efficiency of this system was 
compared to a TALEN system targeting the same region (Mali et al., 2013; Sanjana et al., 
2012). The successful correction rates of the CRISPR system ranged from 3% using the first 
gRNA (T1) to 8% using the second gRNA (T2). The correction rate using TALEN was 
similar. Compared to the TALEN system, the RNA-mediated editing process was twice as 
quick with results appearing within 20 hours as compared to 40 hours with TALEN. Results 
suggested that RNA-guided genome editing was promising, as using the CRISPR/Cas9 
system was much more efficient and economical than both ZFNs and TALENs (Mali et al., 
2013).  
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Recently, two studies (Jinek et al., 2014; Nishimasu et al., 2014) have shed light on 
the structural conformation of Cas9 and the structural mechanisms of RNA-guided DNA 
cleavage by Cas9. Through these studies, it was observed that the Cas9 family of proteins is 
characterized by six nuclease domains. The HNH domain is a single nuclease domain, while 
the RuvC domain contains three subdomains. Both the HNH domain and RuvC domain 
initiate single-stranded DNA cuts. The RuvC I subdomain is near the N-terminal region of 
Cas9 while the RuvC II and RuvC III subdomains flank the HNH domain near the middle of 
the protein. All Cas9 proteins also have two REC domains. The REC I domain is responsible 
for binding gRNA while the protospacer-adjacent motif (PAM) interacting domain is 
responsible for initiating binding of target DNA. The arginine-rich bridge helix then contacts 
between 8 to 10 nucleotides on the 3’ end of the target DNA and initiates cleavage. The 
function of the REC II domain is unknown to-date (Fig. 3) (Jinek et al., 2014; Nishimasu et 
al., 2014).  
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Figure 3: Schematic diagram, crystal structure and map form of the Cas9 protein. The 
Cas9 protein contains 6 domains: RuvC, Bridge Helix, Rec I and Rec II, HNH and PAM 
interacting. (Modified from https://sites.tufts.edu/crispr/crispr-mechanism/ website 
maintained by Tufts University and Jinek et al., 2014) 
 
Currently, Streptococcus pyogenes Cas9 (SpyCas9) is the Cas9 enzyme that is used in 
most CRISPR genome engineering applications. Through a series of biochemical assays and 
single particle electron microscopy, the crystal structure of SpyCas9 was observed more 
closely in order to better understand how the enzyme functions within the CRISPR/Cas9 
system. Through these experiments, it was observed that in the absence of nucleic acids, the 
enzyme maintains an auto-inhibited conformation which prevents binding. In other words, 
when the enzyme is not bound to target DNA or gRNA, SpyCas9 exhibits a conformation in 
which the HNH domain active site is blocked by the RuvC domain, while also being 
positioned away from the REC lobe. However, when SpyCas9 comes in contact with gRNA, 
the enzyme reorients itself into a position where the catalytic centers are on opposite ends. 
This RNA- induced repositioning is likely to enable the enzyme to bind to target DNA.  
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(Jinek et al., 2014). In addition, binding of the gRNA to the DNA can be sterically inhibited 
by the orientation of the C-terminal domain, causing Cas9 to be unable to bind and cleave the 
target DNA (Nishimasu et al., 2014). Together, these studies suggest that the gRNA serves as 
a scaffold for Cas9, allowing it to fold and organize its various domains (Jinek et al., 2014; 
Nishimasu et al., 2014).  
Using the CRISPR system, Cas9 can be directed to the target site in two ways. The 
first way is by a pair of RNA molecules containing a crRNA and a tracrRNA. Alone, neither 
of these molecules can direct DNA cleavage via Cas9. Both the crRNA and tracrRNA must 
be present for Cas9 to cleave target DNA (Jinek et al., 2012). The second way to direct the 
Cas9 is with a chimeric short guide RNA (sgRNA). Both the crRNA and the sgRNA contain 
a 20-nucleotide sequence that directly match the target DNA sequence. The RNA molecule is 
able to recognize the DNA via Watson-Crick basepairing. (Choe et al., 2013; Cong et al., 
2013; Jinek et al., 2013; Mali et al., 2013). 
Alone, crRNA is unable to direct Cas9 to cleave target DNA. Using an 
electrophoretic mobility shift assay (EMSA), it has been observed that there is very little 
specific DNA binding with Cas9 alone, or with both Cas9 and crRNA together; however, 
when using Cas9 and crRNA in combination with tracrRNA, Cas9 is able to cleave the target 
sequence at a substantially higher rate. This indicates that tracrRNA is required for target 
DNA recognition and cleavage by Cas9. This is because the tracrRNA is able to properly 
orient the crRNA for interaction with the complimentary target DNA (Jinek et al., 2012).  
The location of site-specific cleavage is dictated by both base-pair complementarity 
between crRNA and DNA, as well as the PAM of Cas9. While the required PAM recognition 
sequence varies depending on the species of Cas9, a typical PAM sequence for SpyCas9 is 5’ 
25 
 
N-G-G 3’ where the sequence begins with any nucleotide immediately followed by two 
guanines. The PAM recognition sequence is located immediately downstream of the target 
DNA and directs the target search mechanisms of the Cas9 protein (Jinek et al., 2012). The 
Cas9-gRNA complex associates with PAM sequences throughout the genome; however, if 
the gRNA does not match the DNA sequence, the Cas9 continues to search for the correct 
target sequence. Ultimately, the Cas9 will interact with a PAM sequence that directly follows 
the correct target DNA sequence (Fig. 4) (Jinek et al., 2014; Nishimasu et al., 2014; 
Sternberg et al., 2014). Once this occurs, the Cas9 nuclease domains are activated and the 
Cas9 will be able to flank the 3’ end of the target DNA (Nishimasu et al., 2014; Shah et al., 
2013). 
Once the Cas9 protein has been guided to the target DNA via the RNA molecule(s), 
the Cas9 nuclease cleaves DNA through both the RuvC domain and HNH domain. Each 
domain then cuts one strand of DNA, the HNH domain cleaves the complimentary strand 
while the RuvC domain cleaves the non-complementary strand, ultimately generating double 
stranded breaks (DSBs) with blunt ends (Fig. 4) (Gasiunas et al., 2012; Jinek et al., 2012; 
Sapranauskas et al., 2011).  These DSBs then stimulate a repair mechanism. Normally, DSBs 
initiate repair through non-homologous end joining (NHEJ) or homology-directed repair 
(HDR) which are both active in most cell types and organisms (Cong et al., 2013; Maruyama 
et al., 2015). HDR occurs only during the S and G2 phases of the cell cycle, meaning it 
occurs less frequently than NHEJ which occurs throughout all phases of the cell cycle 
(Maruyama et al., 2015).  
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Figure 4: Schematic diagram depicting the interaction between the Cas9 nuclease 
(pink), the gRNA sequence (green) and the double stranded DNA (blue). Prior to 
binding, the Cas9/ gRNA complex targets the PAM sequence (red). Once the complex 
interacts with the correct PAM sequence and the gRNA is complimentary to the DNA, the 
gRNA and DNA form a heteroduplex. Next, the RuvC domain and the HNH domain of the 
Cas9 enzyme each cut a single DNA strand, ultimately generating a double stranded break. 
(Image acquired from www.ozbiosciences.com) 
Non-homologous end joining is not the most precise method of repair for efficient 
genome editing. Often, NHEJ repair mechanisms leads to imperfect or frameshift repairs. 
This type of repair is thought to introduce insertions and deletions of random lengths which 
can lead to mosaicism in CRISPR-modified organisms (Maruyama et al., 2015). While HDR 
and NHEJ occur concurrently, HDR is increased in cells that are incapable of repair through 
NHEJ. Since NHEJ is not the most precise method to repair DSB, HDR was stimulated at the 
expense of NHEJ by targeting DNA ligase IV, a key enzyme in the repair mechanism used 
by the NHEJ pathway. Using the CRISPR/ Cas9 system, DSB were introduced in 
mammalian cells. At the same time, Scr7, a previously proven inhibitor of DNA ligase IV, 
was used to inhibit the NHEJ pathway. By inhibiting the NHEJ repair mechanisms, the 
efficiency of HRD mediated repair in mammalian cells increased 19-fold. Not only can this 
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be used to increase the precision and efficiency of repair after DSB from the CRISPR/ Cas9 
system, this application could also be applied to other genome editing tools such as ZFNs and 
TALENs. Also, because NHEJ and HDR use similar molecular mechanisms throughout 
eukaryotes, this application could be applied to other mammalian cells, as well as non-
mammalian cells with sufficiently conserved mechanisms (Maruyama et al., 2015). 
Ultimately, this finding could lead to a huge increase in repairing DSBs after genome editing, 
leading to higher efficiency and better results.  
Another way to improve the repair mechanisms associated with breaks generated by 
Cas9 is to mutate the Cas9 endonuclease. Cas9 can be mutated by inactivating either the 
RuvC domain or the HNH domain. After being mutated, Cas9 acts as a DNA nickase that 
creates a single stranded break (SSB). Single stranded breaks are repaired through the high-
fidelity base excision repair (BER) pathway, generating a more precise and specific repair 
mechanism than through NHEJ and HDR. Because SSB are repaired more effectively than 
DSB, another way to possibly improve on-target DSB specificity would be by using a 
double-nicking approach, similar to the approach used in ZFNs and TALENs (Mali et al., 
2013b; Ran et al., 2013). By using a pair of gRNAs and a mutated Cas9 endonuclease with 
only one active domain (HNH+/Ruvc- or HNH-/RuvC+), nicks can mimic DSBs and mediate 
efficient insertions and deletions. Also, by using a double-nicking approach, off-target nicks 
are precisely repaired. Theoretically, this would improve specificity by 1,500X as compared 
to the wildtype Cas9 endonuclease (Ran et al., 2013).  
The CRISPR/Cas9 system has been previously shown to work effectively for both 
knock-in and knock-out applications. These alterations can range from a single base-pair to 
multiple sites throughout the genome (Shalem et al., 2014). Compared to previous genome 
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engineering technology, CRISPR has proved to be efficient at generating deletions/ insertions 
and genetically altered karyotypes (Guo et al., 2015). Multiple studies have looked at altering 
human stem cells via the CRISPR/Cas9 system (González et al., 2014; Mali et al., 2013; Zhu 
and Huangfu, 2013). Human pluripotent stem cells (hPSC) have the ability to generate all 
adult cell types, including uncommon and isolated cell populations. This offers a unique way 
to study diseases that may not be available otherwise.  
In addition to being effective in vitro, the CRISPR/ Cas9 system has also been 
effective in vivo. A breakthrough in the genome engineering field came when the 
CRISPR/Cas9 system was shown to be able to induce mutations at rates similar to, or better 
than, both TALENs and ZFNs in zebrafish embryos. In 2013, Hwang et al. generated several 
gRNAs that targeted the fh gene of zebrafish. The majority of these targets in the zebrafish fh 
gene were successfully mutated and showed robust mutations using the CRISPR/Cas9 
system. Two of these successful targets had previously been unable to be mutated through 
either TALENs or ZFNs. For the other mutations, success rates were comparable to TALENs 
and ZFNs. These results show that using gRNA to direct site-specific DNA cleavage via 
Cas9 is a rather fast and highly efficient method for altering genes in vivo, opening the door 
for using the CRISPR/Cas9 system in other organisms (Hwang et al., 2013).   
In addition to being comparable to other genome engineering techniques in vivo 
(Hwang et al., 2013), CRISPR/Cas9 also appears to be both highly efficient and precise in 
generating heritable mutations in zebrafish. In a different study conducted in 2013, Hruscha 
et al. designed four different gRNAs to target four different genomic loci. Injected fish were 
screened via PCR and RFLP and it was observed that mutagenesis reached up to 86.0% while 
off target effects were relatively low ranging from 1.1-2.5%. Because injected fish display 
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mosaicism, the transmission from injected fish (PO) to offspring (F1) was also observed as 
three of seven F1 clutches (43%) carried the mutation. This rate of germline transmission 
efficiency is comparable to the 45% that has been previously observed with ZFNs. Overall, 
this study demonstrates that CRISPR/Cas9 is efficient for inducing heritable mutagenesis 
with low off-target effects, with rates comparable to other genome editing tools. Compared to 
ZFNs and TALENs, the CRISPR/Cas9 system is cheaper and less time consuming to 
generate, making it a great tool for genome editing in zebrafish (Hruscha et al., 2013). 
A common standard for targeted mutagenesis in zebrafish is gol. The gene encodes 
the slc24a5 cation exchanger which has been shown to effect pigmentation in both humans 
and zebrafish (Lamason et al., 2005). In 2013, Jao et al. used the CRISPR/Cas system to 
target the gol gene in zebrafish. Mutation in the gol gene display lighter melanocyte 
pigmentation that is detectable in zebrafish embryos as early as 48 hpf. Zebrafish carrying 
the homozygous gol mutation show hypopigmentation in skin melanophores and retinal 
pigment epithelium (RPE) (Lamason et al., 2005). At 48 hpf, mosaic hypopigmentation was 
observed in skin melanophores and RPE in 94% of the injected embryos, while mutagenesis 
rates ranged from 78-98%, indicating that most cells contained bi-allelic mutations. Germ-
line transmission of the Cas9 induced mutation was also observed, as well as, recessive null-
like phenotypes suggesting high rates of bi-allelic gene disruption. These results suggest that 
CRISPR/Cas9 is an efficient way to induce bi-allelic gene disruptions in zebrafish (Jao et al., 
2013). This rate of germline transmission efficiency is comparable to the 45% that has been 
previously observed with ZFNs. This results in mosaicism of mutant and wildtype alleles. 
While this incomplete mutagenesis is necessary for generating germline mutants and permits 
higher rates of embryo survival, recent reports have shown increased mutagenesis efficiency 
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upon injection of in vitro assembled Cas9-sgRNA ribonucleoprotein complexes (RNPs) 
(Gagnon et al.,2014; Kotani et al., 2015; Sung et al., 2014).   
In 2016, Burger et al. used in vitro assembled Cas9-sgRNA ribonucleoprotein (RNPs) 
complexes to recapitulate loss of function phenotypes in zebrafish embryos (2016). tbx16 is a 
T-box gene that is regulated by FGF signaling. In homozygous mutant spadetail (spt) 
embryos, tbx16 is defective resulting in embryos displaying a broad posterior tail. This 
mutant phenotype is attributed to the failure to differentiate mesoderm progenitor cells from 
different lineages (Kimmel et al., 1989). When Burger et al. used RNPs to target spt, more 
than 60% of all embryos injected displayed a strong phenotype while almost 20% displayed a 
mild or partial phenotype. Using MiSeq along with a customized software tool, 
CrispRVariants, for quantifying and visualizing mutagenesis, it was shown that RNPs allow 
for efficient bi-allelic mutagenesis for both golden and spadetail (Burger et al., 2016). 
Zebrafish are not the only model organism being used in CRISPR/Cas9 experiments. 
In 2014, Long et al. was able to correct a germline mutation in mouse embryos to ultimately 
prevent muscular dystrophy using the CRISPR/ Cas9 system. Duchenne muscular dystrophy 
(DMD) is a genetic disease that mainly effects males, although female cases do occur. On 
average, 1 in 3,500 boys are affected. DMD is caused by mutations to the gene that encodes 
for dystrophin, an important protein in muscle fibers. To-date, there is no cure for muscular 
dystrophy and those effected normally have a shortened life span. A transgenic line of mice 
was generated that possessed the mutation for DMD. Using the CRISPR/Cas9 system, a 
recent study looked at the possibility of correcting the nonsense mutation in mouse embryos 
in vivo. By injecting Cas9, gRNA and an HDR template into mouse zygotes, Long and 
colleagues were able to correct the nonsense mutation in the germ line of mice possessing the 
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mutated gene. The genetically altered animals contained 2 to 100% correction of the 
mutation, with the variation being due to mosaicism. However, the degree of phenotypic 
muscle rescue greatly exceeded the degree of gene correction. Genetically altered mice that 
had just 17% gene correction (due to mosaicism) displayed between 47-60% corrected 
dystrophin fibers as compared to mice suffering from DMD. This striking result could 
possibly allow for mice with only a small percentage of gene correction to live a near normal 
life as compared to those mice with 0% corrected dystrophin fibers as seen in DMD. Also 
observed throughout this experiment was that mice expressed higher and higher levels of 
gene correction over time, leading to the hypothesis that corrected genes are rescuing 
mutated genes as time proceeds. Important to note, all genetically altered mice developed to 
the adult stage with no signs of tumors or other side effects associated with the injections. 
This study presents a hopeful approach to promote muscle repair in patients with DMD 
(Long et al., 2014).  
Current applications of the CRISPR/Cas9 system include, but are not limited to, 
changing sequences in pluripotent embryonic stem cells (González et al., 2014; Mali et al., 
2013a; Zhu and Huangfu, 2013) and correcting genetic defects in animals (Long et al., 2014). 
While these studies are laying the foundation for refined approaches that could one day treat 
human disease and genetic defects, there are many bioethical questions to address before the 
first human germline engineering project can begin. While engineering the human germline 
is not a new idea, both excitement and unease have long surrounded the topic. To begin with, 
both the safety and efficiency of the technology must be insured. Next is the ethical question 
of whether or not it is appropriate to alter a disease-causing mutation to a more typical 
sequence? It is also critical to think about the on-target events that produce unintended 
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consequences, as well as the off-target effects of these modifications. Aside from the ethical 
questions and concerns, using the CRISPR/Cas9 system on human subjects would need to be 
approved by the Food and Drug Administration (FDA) in the United States (Baltimore et al., 
2015).     
In conclusion, genetic engineers have been able to insert and delete genes for 
decades; however, they were unable to dictate the precise location of these modifications. 
Around a decade ago, ZFNs and TALENs allowed DNA to be broken at specific targets but 
having to generate custom designed proteins is time consuming and expensive. The 
CRISPR/Cas9 system uses the same protein and only requires custom designed gRNAs, 
making it a much simpler and less expensive system. The benefits of the CRISPR/Cas9 
system include efficiency, precise targeting, flexibility to be used in numerous systems and 
the economical price as compared to genetic engineering technology of the past (Doudna and 
Charpentier, 2014). The CRISPR system has already assumed a position beside TALENs and 
ZFNs in the genome engineering toolbox and the ease of retargeting the CRISPR/Cas9 
system to modify genomic sequences far exceeds that of ZFNs and TALENs, while offering 
similar rates of efficiency (Mali et al., 2013b). Aside from the bioethical questions 
concerning the system, it could potentially revolutionize genome editing as it could be used 
to treat diseases in humans such as HIV, correct birth defects such as trisomy 21 (down 
syndrome), and more. The CRISPR system has quickly become one of the most versatile and 
powerful tools in genome engineering and with much more to learn, the possibilities are 
endless. Here I make use of the system to excise a regulatory element from the zebrafish 
genome to study the role it plays in regulating genes with which I believe it to be associated.  
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This project increases the knowledge and understanding of the regulatory 
mechanisms associated with the Meis2 gene. The activity of the m2de1 element was 
observed in order to determine when and where the element is active during the development 
of zebrafish embryos through use of a reporter transgene. This pattern was then compared to 
the spatial and temporal expression patterns of meis2a and zgc:154061 in order to visualize 
overlaps between the expression directed by m2de1 and the expression of both meis2a and 
zgc:154061. Upon observation of overlapping expression patterns, a portion of m2de1 was 
excised from the zebrafish genome and the expression patterns of meis2a and zgc:154061 
will be compared in wildtype embryos and m2de1 mutant embryos. As differing expression 
patterns were observed between wildtype and mutant embryos, insight has been gained into 
the regulatory mechanisms associated with the zebrafish meis2a gene.  
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Materials and Methods 
Zebrafish husbandry  
Zebrafish were cared for as described in The Zebrafish Book: A guide for the 
laboratory use of zebrafish (Danio rerio) (Westerfield, 2000) and all animal use was 
approved in accordance with the Appalachian State University Institutional Animal Care and 
Use Committee (IACUC) and. Fish were housed in a Marine Biotech Z-mod closed system 
(Aquatic Habitats, Apopka, FL). Within the system, fish were kept in one-liter tanks with a 
maximum of 7 adults per tank. Temperature was maintained between 26-28° C, pH was 
maintained between 6.8 and 7.2, while conductivity was kept between 450 and 600 
microSiemens. These environmental parameters were monitored daily. Water hardness was 
monitored monthly and maintained between 120-200ppm. Fish were on a systematic light 
cycle of 14 hours of light and 10 hours of dark. During light hours, adult fish were fed dry 
food once a day before noon and live brine shrimp daily in the afternoon. 
Breeding 
In order to obtain embryos for injections, male and female fish were separated by a 
divider in a special breeding tank (Aquatic Habitats). By dividing the fish, we were able to 
control when the fish spawned. Fish remained divided overnight and the divider was 
removed at approximately 9:00 in the morning when the system lights first turned on. 
Females began to release eggs that were fertilized by the male fish and then fell through the 
mesh bottom of the breeding tank. Fifteen minutes after the divider was pulled, embryos 
were collected. This allowed time to ensure that embryos were still at the single cell stage for 
injections. Collected embryos were filtered through a fine mesh net and then rinsed with RO 
water to clean them from debris such as fecal matter. 
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The clean eggs were then placed into a petri dish containing 0.3x Danieau buffer (58 
mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5 mM HEPES pH 7.6 for 1x 
solution). If the embryos were to be raised to adulthood without injections or imaging, they 
were placed in a 1x Danieau/ methylene blue solution (66.66μL 1% methylene blue per liter 
of 1x Danieau buffer) in order to prevent fungal growth. The embryos were then placed in a 
28°C incubator for the first five days post fertilization. After this time, larval fish were 
moved into standard 1L tanks. The tank was filled with 50% 1x Danieau buffer and 50% 
system water and placed on a very slow drip of system water. The larval fish were fed dry 
food (Zeigler) twice a day based on their size.  ZM-50 food was fed approximately between 5 
dpf until 11 dpf. ZM-100 was fed approximately between 2 and 3 weeks post fertilization. 
ZM-200 was fed between 3 and 6 weeks fertilization before moving to ZM-300 and ZM-400 
until approximately 3 months post fertilization. After approximately 3 months, zebrafish 
were fed standard adult food (Zeigler Adult Zebrafish Complete Diet). Once larval fish began 
eating ZM-200, they were also fed 2-day-old brine shrimp. Once larval fish began their diet 
of brine shrimp, they only received dry food once a day in the morning and live brine shrimp 
in the afternoon. After fish reached sexual maturity between 2-4 months of age, they were 
fed adult dry food in the morning and one concentrated drop of live brine shrimp per fish in 
the afternoon. 
Transformations 
In order to obtain sufficient amounts of plasmid DNA, it was first transformed into 
bacterial cells. To do this, approximately 25-50 ng of plasmid (no more than 2μL) was added 
to 50μL of chemically competent DH5α E. coli. The competent cells were then incubated on 
ice for 30 minutes before being heat shocked at 42°C of 45 seconds. Cells were then placed 
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back on ice for 5 minutes before carefully being added to 1mL of SOC medium (20g bacto-
tryptone, 5g bacto-yeast extract, 0.5g NaCl, 20mM glucose) followed by an incubation 
period of 1 hour at 37°C and 180rpm. After the incubation, the cells were plated at volumes 
of 25μL, 50μL and 100μL on LB agar plates that contained the appropriate antibiotic for 
selection. Plates were then incubated overnight at 37°C before being wrapped in parafilm 
wax the next morning and being stored at 4°C. 
Transcribing Transposase mRNA 
Transposase mRNA was transcribed using the mMessage mMachine Sp6 kit 
(Ambion, Life Technologies, Grand Island, NY). The protocol provide by the manufacturer 
was used. Once the DNA had been transcribed into mRNA, the mRNA was cleaned and 
concentrated using the RNA Clean & Concentrator™-5 kit (Zymo Research Corporation) by 
following the protocol provided by the manufacturer. The transposase mRNA was then 
resuspended in RNAse free DEPC water and coinjected with the expression construct, 
dr.m2de1-pGW-cfos-EGFP, into single cell zebrafish embryos.  
Generating Transgenic Embryos through Microinjections with Tol2 mRNA 
Fertilized zebrafish embryos were collected within 15-30 minutes of mating. 
Embryos were washed with RO water and cleaned of any debris by using a Pasteur pipet. 
The clean embryos were then placed in a glass petri dish. Excess water was removed from 
the dish and replaced with Danieau buffer solution (50x 2.9 M NaCl, 35 mM KCl, 20 mM 
MgSO4, 30 mM Ca(NO3)2, 250 mM HEPES pH 7.600, adjusted to 1L in RO water).  
While adult zebrafish were mating, the injection solutions were thawed. Once thawed, 
180 ng of transposase mRNA, 135 ng plasmid DNA (expression vector plasmid carrying 
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dr.m2de1-pGW-cfos-EGFP) were combined and brought to a final volume of 3μL with 
DEPC water. Needles for injections were pulled from a 3.5nl capillary that had been baked at 
a temperature of 260°C in order to insure the inactivity of RNases. The capillary tube was 
secured in a David Kopf Instruments Vertical Pipette Puller model 700C, where the heater 
was set to 54 volts and the solenoid set at 10 amps. The weight on the bottom of the machine 
was used to pull and divide the needle. The tip of the needle was then beveled using size 5 
forceps and filled with mineral oil. The needle was then placed on the Nanoliter 2000 
Microinjector (World Precision Instruments Model B203XVY) which was attached to a 
Marhauser MMJR Micromanipulator (World Precision Instruments). Using the controls on 
the micromanipulator, approximately 20-25% of the mineral oil was pushed out of the 
beveled needle to ensure that the tip was not clogged. The mineral oil was then replaced with 
the injection construct. 
Once the construct filled needle was ready, between 40 and 60 single cell embryos 
were placed against a 1.0-millimeter-thick VWR micro slide (VWR international 48300-025) 
which was taped to the outside of a plastic petri dish to insure stabilization. Single cell 
embryos were then injected with approximately 1 nl of construct. To ensure that the construct 
was injected directly into the single cell of the developing embryo, a translucent bolus was 
observed as the construct was dispensed into the single cell. Inside the embryo, the mRNA 
was translated into transposase protein. The protein then uses the Tol2 sites (Kawakami et 
al., 2004; Kwan et al., 2007) on the expression construct in order to insert the expression 
construct into the zebrafish embryo genome. 
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Screening Tol2 Injected Embryos to Identify Transgenics 
In order to generate a stable transgenic line of zebrafish using the m2de1 element to 
direct the expression of eGFP, primary injected embryos were screened for eGFP expression 
to confirm the presence of the construct. Previous experiments in primary injected embryos 
had noted eGFP expression between 48 and 54 hpf, so these time points were used for 
imaging in order to identify eGFP positive embryos from those embryos that were eGFP 
negative. Because embryos expressing eGFP were to be raised to adulthood for the purpose 
of breeding, a non-invasive method of screening was used. Embryos younger than 72 hours 
were dechorionated under a microscope using #5 watchmaker forceps. The chorions were 
then removed from the petri dish to avoid autofluorescence. Embryos were anasthesized in a 
Pyrex 60x15 mm petri dishes (Corning Like Sciences, New York) that contained about 6 ml 
of 0.3x Danieau buffer and 6 drops of 20% Tricaine suspended in a 0.3x Danieau buffer. The 
Tricaine served as an anesthesia for the embryos, which allowed them to be imaged under the 
fluorescent lamp of the microscope. A Zeiss LSM 510 Confocal Microscope was used to 
view and sort the embryos. Specifically, the 10x objective lens, the FITC filter and bright 
field were used to visualize the fluorescence from eGFP. Embryos that expressed eGFP were 
transferred into a separate dish specifically for eGFP positive embryos.   
Imaging of Transgenic Embryos 
Once eGFP positive embryos were sorted from eGFP negative embryos, a Zeiss LSM 
880 Confocal Microscope was used to image the anesthetized embryos. The Argon laser was 
used to collect images of the fluorescent embryos. Image collection ranged from single slice 
pictures to Z-stacks. The quality of the pictures remained constant at 1024x1024 and the 
scanning speed ranged between 5 to 9. Size rulers were added to images via Zeiss’ built-in 
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software and then using Adobe Photoshop, the green levels throughout the entire picture 
were revised in order to reduce autofluorescence.    
Designing guide RNAs 
To knockout a portion of m2de1 in zebrafish using the CRISPR/Cas9 system, gRNAs 
were designed using CRISPRscan developed by the Giraldez Lab at Yale University. In 
zebrafish, the m2de1 element is located on chromosome 17: 52,911,113-52,911,563 
according to GRCz10/danRer10. This region was examined for potential gRNAs (Fig. 11). 
When examining potential gRNAs, the sequence in between two gRNAs was entered into the 
Patch 1.0 database on gene-regulation.com, in order to determine whether or not there were 
transcription factor binding sites between the two gRNAs (Fig. 12).  
Transcribing guide RNAs 
To generate templates for gRNA transcription, a specific oligonucleotide containing 
the T7 promotor sequence (5’-TAATACGACTCACTATA-3’), the target sequence (short 
guide oligo), and a complementary sequence were annealed to a guide constant (scaffolding) 
oligo (Table 2). Samples were prepared for the thermocyler containing 5μL 5x Phusion 
buffer, 0.5 μL dNTPs, 3μL of 10μM short guide oligo, 3 μL of 10 μM scaffolding oligo and 
0.25μL of Phusion. The sample was brought to a total volume of 25μL with nuclease free 
water. The sample was then placed in the thermocycler. The following settings were used to 
carry out the polymerase chain reaction (PCR): initial denaturation of 98°C for 30 seconds 
followed by 45 cycles of normal denaturation of 98°C for 10 seconds, annealing at 60°C for 
10 seconds and extension at 72°C for 15 seconds. Once 45 cycles were completed, the 
sample underwent a final extension at 72°C for 5 minutes. The samples then remained at 4°C 
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until they were removed from the thermocycler. Once the samples were removed from the 
thermocycler, they were purified using phenol chloroform extraction. The reaction volume 
was raised to 100μL using nuclease free water. An equal amount of 
Phenol/Chloroform/Isoamyl alcohol (25:24:1) was added to the sample. The sample was then 
mixed by gently flicking the tube before centrifuging for 5 minutes at 16,000 rpm. After 
centrifugation, there were two distinct layers in the tube. The aqueous phase containing the 
DNA was less dense than the organic phase, resulting in the aqueous phase being the top 
layer. The top layer containing DNA was transferred into a new Eppendorf tube and 100μL 
Chloroform/Isoamyl alcohol was added. The sample was mixed and centrifuged as described 
previously. The upper layer was again transferred into a new Eppendorf tube and 2.5 
volumes of 100% ethanol was added. Sodium chloride was then added to the mixture at a 
total volume of 0.2M. Once salt and ethanol were added, the DNA was allowed to precipitate 
for at least 2 hours at -20°C. After incubation, the sample was centrifuged for 30 minutes at 
16,000 rpm at 4°C. The ethanol was then decanted off, with remaining ethanol being 
removed via micropipette. To wash the pellet, 1mL of 70% ethanol was added to the 
Eppendorf tube. The sample was gently mixed by flicking the tube before being centrifuged 
one last time at room temperature at 16,000 rpm for 5 minutes. Again, the ethanol was 
decanted before removing small amounts of ethanol via micropipette. The Eppendorf tube 
was then left for 10-20 minutes to allow the remaining ethanol to evaporate off of the DNA. 
Once the pellet was dry, the DNA was resuspended with 10μL of nuclease free water. After 
allowing the sample to rehydrate, the DNA was used as a template to transcribe gRNAs. 
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Table 2: A template short guide oligo for gRNA synthesis.  
Oligo Name Sequence 
Short Guide 
Oligo 
AATTAATACGACTCACTATAGGNNNNNNNNNNNNNNNNNN 
GTTTTAGAGCTAGAAATAGC 
Guide 
Constant 
Oligo 
AAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGAC 
TAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC 
* Guide oligos are made of three main parts: a T7 promoter, shown in blue, a variable 
targeting sequence, underlined, and an overlap with the guide constant oligo. A short clamp, 
shown in red, is provided to stabilize the 5ʼ end of the sequence. Using PCR, the guide 
constant oligo, shown in purple, and short guide oligo are annealed together to generate a 
full-length template for gRNA synthesis. The guide constant oligo is used as a Cas9 binding 
scaffold. 
 
 gRNAs were then transcribed using the MAXIscript T7 Transcription Kit (Ambion, Life 
Technologies, Grand Island, NY) according to the manufacturer’s protocol with two 
exceptions. To ensure that the transcribed gRNA was not immediately degraded, 1 μL of 
RNAse inhibitor (Promega N2515) was added to the transcription reaction. Also, to ensure 
that the majority of the template DNA was transcribed into gRNA, the reaction was 
incubated overnight rather than the recommended one hour. After the overnight incubation 
period, turbo DNAse was added and the sample was incubated for 15 more minutes. 
Afterwards, the gRNA was cleaned and concentrated using the RNA Clean & 
Concentrator™-5 kit (Zymo Research Corporation) by following the manufacturer’s 
protocol. The gRNA was then resuspended in DEPC water and coinjected with EnGen® 
Cas9 NLS (NEB Mo646T) into single cell zebrafish embryos. 
Generating Transgenic Embryos through Microinjections using the CRISPR/Cas9 system 
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Fertilized zebrafish embryos were collected and cleaned as previously described.  
While adult zebrafish were mating, the injection solutions were thawed. Once thawed, 50 
ng/μl of each gRNA and 250 ng/μl of EnGen® Cas9 NLS (NEB M0646T) were combined 
and brought to a final volume of 4μL with nuclease free water. The construct was then 
incubated at 37°C for 10 minutes to allow the Cas9 and the gRNAs to reconstitute (Sternberg 
et al., 2014). A needle for injections was pulled and prepared as described previously. Once 
the needle and construct were ready, single cell embryos were aligned and injected as 
previously described. Each embryo was injected with approximately 1 nl of construct. 
DNA Isolation from Zebrafish Fin Clips 
In order to isolate genetic material from adult fish for the purpose of identifying 
transgenesis, a small amount of tissue was clipped from the distal tip of the caudal fin. The 
tissue was then used to extract DNA which was used for further analysis using PCR. Fish 
were anesthetized with ice cold water. Once the fish was no longer responsive, but still had 
gill movement, sterile tweezers and scissors were used to hold and clip the caudal fin. The fin 
clip was then transferred into 50μl of activated genomic extraction buffer (10mM tris pH 8.0, 
10mM EDTA, 200 mM NaCl, 0.5% SDS, 200 μg/ml Proteinase K in sterile RO water right 
before use). Fish were quickly returned to a recovery tank containing system water and a 
bubbler. Once they began swimming, fish were placed back in the Marine BioTech ZMod 
and maintained in isolation for 2 weeks or until at least 50% of the fin has regenerated. 
The tissue in the genomic extraction buffer was then incubated in a shaking incubator 
at 56°C and 100 rpm for a minimum of three hours or until tissue was completely dissolved. 
Once the tissue was completely dissolved, 2 volumes, or 100μL of 100% ethanol was added 
to the microcentrifuge tube and stored at -20°C overnight. The next morning, the tissue was 
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centrifuged for 10 minutes at 13,000 rpm, afterwards the supernatant was decanted off, being 
careful not to disturb the visible pellet. To wash the pellet, 200μL of 70% ethanol was added 
to the tube and briefly vortexed. The tube was again placed in a microcentrifuge for 2 
minutes at 13,000 rpm. The supernatant was removed once again and the pellet was left to 
dry. Once the pellet was dry, it was resuspended in 20μL of TE+RNAse buffer (10mM Tris, 
1 mM EDTA pH 8.0, RNAse in sterile RO water at a concentration of 100μg/mL) and 
incubated at 37°C for 1 hour. The genomic DNA was then cleaned of contaminants using 
Phenol/Chloroform/ Isoamyl alcohol.  
DNA extraction from zebrafish embryos 
In order to isolate genetic material from zebrafish embryos for the purpose of 
identifying transgenesis, larvae were first euthanized with Tricaine (4% in Danieau buffer) 
between 48 and 72 hpf. Larvae were then washed three times with sterile RO water. Once 
washed, 5 larvae were placed in an Eppendorf tube containing 50μl of activated genomic 
extraction buffer (10mM tris pH 8.0, 10mM EDTA, 200 mM NaCl, 0.5% SDS, 200 μg/ml 
Proteinase K in sterile RO water right before use). The protocol from DNA Extraction from 
Zebrafish Fin Clips (pages 41-42) was then followed for the remainder of the DNA 
extraction. 
Screening Primary Injected CRISPR/ Cas9 Fish to Identify Transgenics  
In order to determine whether a portion of m2de1 was knocked out of the genome in 
m2de1 CRISPR injected embryos, DNA was isolated from 1/3 of a clutch (approximately 15 
embryos) of injected embryos at 36 hours post fertilization. DNA was amplified using 
specific primers (Table 3) to amplify the entire m2de1 sequence. Samples were prepared for 
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the thermocyler containing 50ng of genomic DNA, 2.5μL 10x Thermopol buffer, 0.5 μL 
dNTPs, 1μL of 10μM Dr-m2de1-3 primer, 1 μL of 10μM Dr-m2de1-5b , and 0.125μL of Taq 
Polymerase (NEB Labs). The sample was brought to a total volume of 25μL with nuclease 
free water. The sample was then placed in the thermocycler. The following settings were 
used to carry out the polymerase chain reaction (PCR): initial denaturation of 95°C for 5 
minutes followed by 30 cycles of normal denaturation of 95°C for 30 seconds, annealing at 
55°C for 30 seconds and extension at 68°C for 1 minute and 45 seconds. Once 30 cycles 
were completed, the sample underwent a final extension at 68°C for 10 minutes. The samples 
then remained at 4°C until they were removed from the thermocycler. Samples were then run 
on a 1% agarose gel at 90 volts for approximately 45 minutes to determine the fragment size.  
Table 3: m2de1 Primers 
Oligo Name Sequence 
Dr-m2de1-3 GCTCATTATAAGGCCGTGCATG 
Dr-m2de1-5b TATACCATGGAGGTCGGGTTTAAAGGAG 
 
Generating Anti-sense and Sense RNA Probes 
 Previously, through an NIH initiative and the NIH Mammalian Gene Collection (MGC) 
project, the full length (1914 basepairs) cDNA clone of zgc:154061 was isolated by the 
Zebrafish Gene Collection (ZGC) (Strausberg et al., 2002). The clone was purchased from 
Open Biosystems (Clone ID: 8334609, Accession: BC124527). To generate an anti-sense 
probe, the plasmid was linearized with SalI. Similarly, the cDNA for the meis2a gene was 
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also purchased from Open Biosystems (Clone ID: 6789004, Accession: BC056515) and 
subcloned into pCMV-sport6.1. The plasmid was then linearized with EcoRI to generate an 
anti-sense probe. To generate sense probes, the plasmid containing zgc:154061 was 
linearized with Xho1 while the pCMV-sport6.1 containing meis2a was linearized with Not1.  
After linearization, the samples were purified through Phenol/Chloroform 
precipitation. The purified product was then used as a template for generating the anti-sense 
RNA probe. The anti-sense DIG-labeled RNA probe was transcribed using the MAXIscript 
T7 Transcription Kit (Ambion, Life Technologies, Grand Island, NY) according to the 
protocol provided by the manufacturer, with three exceptions. Similarly, the sense DIG-
labeled RNA probe was transcribed using the mMessage mMachine Sp6 kit (Ambion, Life 
Technologies, Grand Island, NY) according to the protocol provided by the manufacturer, 
with the same three exceptions. The first exception to the protocol was using DIG RNA 
Labeling Mix, 10x concentration (Roche) in the anti-sense probe transcription reactions 
rather that the uracil nucleotide from the MAXIscript T7 Transcription Kit. Likewise, DIG 
RNA Labeling Mix, 10x concentration (Roche) was added to the sense probe transcription 
reactions in addition to the 2x NTP/CAP provided in the mMessage mMachine Sp6 kit. 
Secondly, to ensure that the transcribed RNA was not immediately degraded, 1 μL of RNAse 
inhibitor (Promega N2515) was added to the transcription reaction. The last exception was to 
ensure that the majority of the template DNA was transcribed into RNA. For this purpose, all 
reactions were incubated overnight rather than one hour. After the overnight incubation 
period, turbo DNAse was added and the sample was incubated for 15 more minutes. 
Afterwards, the RNA was cleaned and concentrated using the RNA Clean & Concentrator™-
5 kit (Zymo Research Corporation) by following the protocol provided by the manufacturer. 
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Afterwards, the RNA was resuspended in 15μL nuclease free water, 137μL of hybridization 
buffer (500 mL formamide, 250 mL 20x SSC, 10 mL 10% Tween-20, 10 mL 0.9 M Na 
Citrate stock, 10 mL of 50 mg/mL torula tRNA stock, 1 mL of 50 mg/mL heparin, 219 mL 
DI H2O) was added to the sample. The resulting RNA was stored at -20°C. 
Fixing Embryos 
 Prior to performing in situ hybridization, embryos were fixed at 12, 18, 24, 36, 48, 54, 60, 66 
and 72 hours post fertilization (hpf). Embryos younger than 18 hpf were fixed in an 
Eppendorf tube while still in their chorions. However, embryos older than 18 hpf were first 
dechorionated using size 5 forceps. After dechorionating older embryos, between 30 and 50 
embryos were placed in an Eppendorf tube. Excess Danieau was removed from the tube and 
replaced with approximately 750μL of 4% paraformaldehyde (PFA). Eppendorf tubes were 
then placed on a shaker (Labrat Gyrotwister) at a speed between 45-50 RPM for ten minutes.  
After ten minutes, PFA was removed and replaced with 750μL of fresh PFA. Embryos were 
then left on the shaker overnight at 4°C or for 4 hours at room temperature. Afterward, 
embryos were transferred into a petri dish containing 1x PBS (8g NaCl, 0.2g KCl, 1.44g 
Na2HPO4, 0.24g KH2PO4, brought to 1L with DI H2O). Embryos that had not been 
previously dechorionated were dechorionated at this point.  Embryos older than 24 hpf began 
to develop melanocytes and were depigmented at this time by transferring embryos to a 3% 
H2O2 solution 1 mL 30% H2O2, 0.05g KOH, brought to 10mL with DI H2O). Embryos 
remained in the solution for approximately 30 minutes or until the pigment disappeared from 
the head/ eyes. After depigmenting, embryos were transferred into a clean petri dish 
containing fresh 1x PBS in order to remove the bubbles from the H2O2. Embryos were then 
transferred into a new Eppendorf tube and PBS was removed and replaced with 
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approximately 800μL 50% MeOH/ 50% PBS. The tubes containing embryos were then 
placed on the shaker table as previously described for 5 minutes. The solution was removed 
after 5 minutes and replaced with 100% MeOH and placed on the shaker table for 5 minutes. 
This was repeated 3 times before storing the fixed embryos at -20°C. 
A second, slightly different method of fixing embryos was also used at times. For this 
method, rather than letting embryos develop melanocytes, embryos were raised in a 1-
Phenyl-2-Thiourea (PTU) solution. PTU was dissolved in a dimethyl sulfoxide (DMSO) 
solution (7.813 grams DMSO brought to a final volume of 100 mL with RO water) (300μL 
PTU in 10mL DMSO). The PTU/DMSO solution was added to 1x Danieau buffer at a final 
concentration of 0.003%. This allowed embryos to continue to develop in the PTU solution 
and melanocytes were prevented from arising. Embryos were then dechorionated and fixed in 
4% PFA as previously described. After fixation, the PFA solution was removed and embryos 
were placed in a PBS solution on a shaker table at room temperature for 5 minutes. After 5 
minutes, the PBS was removed and replaced with fresh PBS. After a second 5 minute 
incubation on the shaker table, embryos were slowly dehydrated in a 50% MeOH/ 50% PBS 
solution before going into a 100% MeOH solution and stored at -20°C. 
 After rehydrating embryos, embryos were digested with Proteinase K. Embryos 
between 24 and 30 hpf were digested with Proteinase K at a concentration of 10ug/mL for 
approximately 16 minutes. Embryos over 30 hpf were digested with Proteinase K at a 
concentration of 10ug/mL (10ug Proteinase K in 1 mL PBT) for 30 minutes. During 
digestion, embryos were placed on a shaker table at room temperature with gentle agitation. 
After digestion, the Proteinase K solution was removed and replaced with 4% PFA. Embryos 
were placed on a shaker table in the PFA solution for 20 minutes. After the incubation, the 
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PFA solution was removed and replaced with PBT. Embryos were placed on a shaker table 
with gentle agitation for 5 minutes. The PBT wash was repeated 2 times. After two PBT 
washes, embryos are ready to begin the prehybridization step where they are incubated with 
500μL of the preheated prehybridization buffer in the water bath at 65°C for 2-5 hours. This 
is described below. 
In situ Hybridization 
 Once embryos were fixed, whole mount in situ hybridization was performed. This is 
normally completed over a three-day period. On day 1, both the prehybridization buffer (500 
mL formamide, 250 mL 20x SSC, 10 mL 10% Tween-20, 10 mL 0.9 M Na Citrate stock, 230 
mL DI H2O) buffer and the hybridization buffer (500 mL formamide, 250 mL 20x SSC, 10 
mL 10% Tween-20, 10 mL 0.9 M Na Citrate stock, 10 mL of 50 mg/mL torula tRNA stock, 
1 mL of 50 mg/mL heparin, 219 mL DI H2O) were preheated at 65°C for approximately 1 
hour. In order to rehydrate previously fixed embryos stored in 100% MeOH, embryos went 
through 3 wash steps. The first wash step was with 50% MeOH/ 50% PBS. While in this 
solution, embryos were placed on a shaker table as previously described for 5 minutes. The 
solution was removed and replaced with PBT (0.1% Tween-20 in 1x PBS) and again placed 
on a shaker table for 5 minutes. This wash step was performed three times, ensuring that all 
PBT was removed. At this point, embryos that were bleached were ready to begin 
prehybridization. 
After rehydration, embryos that were grown in PTU were digested with Proteinase K. 
Embryos between 24 and 30 hours hpf were digested with Proteinase K at a concentration of 
10ug/mL for approximately 16 minutes. Embryos over 30 hpf were digested with Proteinase 
K at a concentration of 10ug/mL (10ug Proteinase K in 1 mL PBT) for 30 minutes. During 
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digestion, embryos were placed on a shaker table at room temperature with gentle agitation. 
After digestion, the Proteinase K solution was removed and replaced with 4% PFA. Embryos 
were placed on a shaker table in the PFA solution for 20 minutes. After the incubation, the 
PFA solution was removed and replaced with PBT. Embryos were placed on a shaker table 
with gentle agitation for 5 minutes. The PBT wash was repeated 2 times.  After two PBT 
washes, embryos are ready to begin the prehybridization step 
Once bleached embryos were rehydrated and embryos grown in PTU were rehydrated 
and digested, 500μL of the preheated prehybridization buffer was added to the embryos. 
Embryos were incubated in the water bath at 65°C for 2-5 hours. After incubation, the buffer 
was removed and 200μL of the hybridization buffer containing the probe at a concentration 
of 1:100 was added. The embryos were left in the buffer overnight at 65°C. The following 
morning, the prehybridization buffer, 2x SSC (17.53g of NaCl, 8.82g of sodium citrate in 1L 
DI H2O, pH 7.0) and 0.2x SSC were preheated to 65°C. Once solutions were preheated, the 
hybridization buffer containing the probe was removed and stored at -20°C. Approximately 
500μL of prehybridization buffer was added and incubated at 65°C for 60 seconds. The 
buffer was removed and replaced with 500μL of 50% prehybridization buffer/ 50% 2x SSC 
and this was then incubated at 65°C. The buffer was removed after 45 minutes and replaced 
with 500μL 2x SSC. This was then incubated for 15 minutes at 65°C. The buffer was 
removed after incubation and replaced with 500 uL 0.2x SSC and incubated for 1 hour at 
65°C.  
 Following the previous wash steps at 65°C, the last buffer containing 0.2x SSC was removed 
and 1mL of PBT was added. The Eppendorf tubes were placed on a shaker table to room 
temperature and agitated for approximately 5 minutes. After the incubation, the PBT was 
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removed and replaced with 1mL of fresh PBT and incubated on the shaker table at room 
temperature. These PBT washes were repeated a total of three times. After the last wash with 
PBT, 500μL of blocking solution (2% goat serum, 2 mg/mL BSA in PBT) was added to 
embryos, which are then placed on a shaker table for 1 hour at room temperature. Following 
blocking, the buffer was removed and replaced with 500μL of antibody solution (1μL of 
Anti-Digoxigenin-AP-Fab fragments (Roche) per 1mL of blocking solution). Embryos were 
left overnight at 4°C on a shaker table with gentle agitation. 
On the following day, the antibody solution was first removed from the Eppendorf 
tube. The embryos were then washed quickly with 500μL of PBT, which was then 
immediately removed.  After the quick wash, embryos were washed six times with 500μL of 
PBT, with each wash lasting for 15 minutes on the shaker table. Next, the embryos were 
washed with 500μL alkaline phosphatase buffer (500 L 1M Tris 9.5, 250 L 1M MgCl2, 
100 L 5M NaCl, 25L 20% Tween-20, 4.125 mL H20). Each wash with alkaline 
phosphatase buffer lasted 5 minutes on the shaker table. A total of 3 alkaline phosphatase 
buffer washes occurred. Following the last wash, 300μL of alkaline phosphatase buffer 
containing color substrate (3.5 L BCIP & 4.5 L NBT per 500 L AP buffer) was added to 
the embryos. The color was allowed to develop in the embryos while keeping the embryos in 
a dark space. Embryos were checked for color development periodically. If color was 
developing slowly, embryos were left in color substrate solution overnight. Once color had 
developed, the reaction was quenched. To quench the color, the color substrate was removed 
and 500μL of PBT was added. Embryos were rinsed three times in PBT. Each rinse lasted for 
approximately 5 minutes and the embryos were on the shaker table with gentle agitation 
during each wash. After the last wash, 500μL of 100% methanol was added. Embryos were 
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incubated at room temperature on a shaker plate for 5 minutes before removing methanol and 
replacing with 500μL of fresh 100% methanol. Embryos were stored in methanol at -20°C.   
Imaging in situ hybridization   
To examine spatial and temporal expression of meis2a and zgc:154061, embryos 
were suspended in a 75% glycerol/ 25% PBS solution overnight. The following day, embryos 
were mounted on a 1.0 mm thick microslide (VWR 48312-004) before covering the sample 
with a 1-ounce 22x22 mm microscope cover glass (VWR 16004-094).  Images were taken 
using an Olympus IX81 inverted microscope. Images were then processed with Olympus 
cellSens Software. 
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Results 
Expression driven by Dr-m2de1 
In order to observe when and where the m2de1 element was active in developing 
zebrafish embryos, single cell zebrafish embryos were injected with pDr m2de1-F-cfos-
EGFP and transposase mRNA. Embryos were then imaged through 72 hpf. It was observed 
that between 48 hpf and 54 hpf, the m2de1 element was actively directing the expression of 
eGFP. At 48 hpf embryos displayed eGFP in the forebrain, midbrain and hindbrain, as well 
as muscle fibers in the head and the trunk (Fig. 5A, B). When embryos were imaged at 54 
hpf, the expression was observed in these same areas (Fig. 5C, D). The expression in each of 
these areas has been observed previously in primary injected embryos (Barrett, 2013; Ferrara, 
2015).  
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Figure 5: eGFP expression driven by Dr-m2de1 in the forward orientation (5’-3’) at 48 
hpf and 54 hpf. eGFP expression is seen in the developing (A) forebrain (red arrow), 
midbrain (black arrow) and hindbrain (orange arrow) and (B) muscle fibers of the trunk 
(purple arrow) of 48 hpf embryos. At 54 hpf, expression can be seen in the (C) developing 
forebrain (red arrow), midbrain (black arrow) and hindbrain (orange arrow), as well as, (D) 
the trunk (purple arrow). All embryos are positioned so that the anterior is to the left and the 
dorsal is to the top.  
 
Spatial and Temporal Expression of meis2a and zgc:154061  
After observing when and where the m2de1 element was active during development, 
the spatial and temporal expression of meis2a and zgc:154061 was observed in order to 
determine whether the expression directed by the element overlapped with the expression of 
either gene. Previously, spatial and temporal expression of meis2a has been reported from the 
2-somite stage until 48 hpf (Bessa et al., 2008; Carpenter et al., 2016; Thisse and Thisse, 
2005; Waskiewicz et al., 2001). Similarly, spatial and temporal expression of zgc:154061 has 
been reported from 1.5 hpf until 48 hpf (Carpenter et al., 2016). In order to observe the 
expression patterns of meis2a and zgc:154061 that have been previously described (Bessa et 
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al., 2008; Carpenter et al., 2016; Thisse and Thisse, 2005; Waskiewicz et al., 2001), in situ 
hybridization was completed at 24 hpf. At this time, in situ hybridization shows overlaps in 
the expression of both meis2a and zgc:154061. Both genes are restricted anteriorly and show 
expression in the telencephalon and diencephalon (forebrain), optic tectum, cerebellum 
(midbrain) and rhombencephalon (hindbrain) (Fig. 6A-D). 
         
Figure 6: Whole mount in situ hybridization on 24 hpf zebrafish embryos to visualize 
meis2a and zgc:154061 expression. meis2a and zgc:154061 expression was observed to be 
localized in the forebrain (red arrow), optic tectum (blue arrow), cerebellum (black arrow) 
and rhombencephalon (orange arrow). (A, B) embryos displaying meis2a expression in the 
(A) lateral orientation and the (B) dorsal orientation. (C, D) embryos displaying zgc:154061 
expression in the (C) lateral orientation and the (D) dorsal orientation. All embryos are 
positioned so the anterior is to the left.   
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Between 48 and 54 hpf, both meis2a and zgc:154061 exhibit overlapping expression 
with that directed by m2de1. At 48 hpf, meis2a (Fig. 7A, D) has an expression pattern similar 
to meis2a expression at 24 hpf. Expression was still seen in the telencephalon and 
diencephalon (forebrain), optic tectum, cerebellum and rhombencephalon. In contrast, at 48 
hpf, zgc:154061 exhibits less localized expression and seems to be expressed at lower levels. 
Expression was seen in the forebrain and retina (Fig. 7B, E). Similarly, at 48 hpf, m2de1 
directed expression to areas around the forebrain, the eye and the midbrain (Fig. 7C, F).  
At 54 hpf, the expression of both genes still overlapped with the expression directed 
by m2de1. At this time point, meis2a became more anteriorly restricted. Expression of 
meis2a was still observed in the forebrain, optic tectum and cerebellum, while expression in 
the retina was also present at this time (Fig. 7G, J); however, the expression observed in the 
rhombencephalon at earlier time points was no longer present. While zgc:154061 still lacked 
definitive localized expression, low levels of expression were observed around the forebrain, 
the retina and the cerebellum (Fig. 7H, K). Again, the expression of both genes overlapped 
with the expression directed by m2de1 at 54 hpf. The expression directed by m2de1 at 54 hpf 
was very similar to the pattern observed at 48 hpf where expression of eGFP was observed 
around the forebrain, the eye and the midbrain (Fig 7I, L). 
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Figure 7: Whole mount in situ hybridization on 48 hpf and 54 hpf wildtype zebrafish 
embryos to visualize meis2a and zgc:154061 expression and expression directed by 
m2de1 in live transgenic embryos of the same age. meis2a and zgc:154061 expression was 
observed to overlap the expression directed by m2de1 in 48 and 54 hpf embryos. At 48 hpf, 
(A, D) embryos displayed meis2a expression in the forebrain (red arrow), optic tectum (blue 
arrow), cerebellum (black arrow) and rhombencephalon (orange arrow) (B, E) embryos 
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displayed zgc:154061 expression in the forebrain (red arrow) and retina (green arrow), while 
(C, F) m2de1 directed expression to areas around the forebrain (red arrow), eye (green 
arrow) and midbrain (black arrow). At 54 hpf, (G, J) meis2a was expressed in the forebrain 
(red arrow), retina (green arrow), optic tectum (blue arrow) and cerebellum ( black arrow) 
(H, K) zgc:154061 was expressed in the forebrain (red arrow), retina (green arrow) and 
cerebellum (black arrow), while (I, L) m2de1 continued to direct expression to areas around 
the forebrain (red arrow), eye (green arrow) and midbrain (black arrow). Sense RNA probes 
served as negative controls at 48 hpf for (M) meis2a and (N) zgc15406. All embryos are 
positioned so the anterior is to the left. Images A-C, G-I and M-N are in the lateral 
orientation and images D-F and J-L are in the dorsal orientation.  
After 54 hpf, the expression directed by m2de1 was no longer detected. However, 
meis2a and zgc:154061 still displayed overlapping expression patterns, specifically within 
the forebrain. Both genes are restricted anteriorly between these time points. At 60 hpf, 
meis2a was no longer observed in the retina as it was at 54 hpf; however, expression was still 
observed in the forebrain, optic tectum and cerebellum (Fig. 8A, G), while embryos for 
zgc:154061 at 60 hpf displayed expression around the retina and forebrain (Fig. 8D, J). At 66 
hpf, meis2a expression was still observed in the forebrain, optic tectum and cerebellum (Fig. 
8B, H). At the same time, zgc:154061 was expressed around the forebrain and retina (Fig. 
8E, K). At 72 hpf meis2a was observed in a similar pattern as observed at 66 hpf. At this 
time, meis2a was still observed in the forebrain, optic tectum and cerebellum (Fig. 8C, I) 
while zgc:154061 expression was observed in the forebrain and retina (Fig. 8F, L).  
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Figure 8: Whole mount in situ hybridization to visualize meis2a and zgc:154061 
expression. At 60 hpf, (A, G) meis2a expression can be seen the forebrain (red arrow), optic 
tectum (blue arrow) and cerebellum (black arrow) (D, J) while zgc:154061 expression is seen 
in the forebrain (red arrow) and retina (green arrow). At 66 hpf (B, H) meis2a expression is 
observed in the forebrain (red arrow), optic tectum (blue arrow) and cerebellum (black 
arrow) and (E, K) zgc:154061 expression is observed in the forebrain (red arrow) and retina 
(green arrow). At 72 hpf, (C, I) meis2a is observed in the forebrain (red arrow), optic tectum 
(blue arrow) and cerebellum (black arrow) while (F, L) zgc:154061 is observed in the 
forebrain (red arrow) and retina (green arrow). All embryos are positioned so the anterior is 
to the left. Embryos A-F are positioned in the lateral orientation while G-L are in the dorsal 
position.  
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CRISPR Injections using a positive control 
To further study the potential role of m2de1 in the expression of meis2a and/or 
zgc:154061, CRISPR/Cas9 was utilized to attempt to remove the element from the zebrafish 
genome. As a first step towards this, several approaches were used to optimize this approach, 
including positive control injections, Cas9 mRNA and Cas9 protein. While Burger et al. 
previously maximized zebrafish mutagenesis with solubilized CRISPR/Cas9 RNPs, 
generating such proteins can be both timely and costly. In our initial test to assess the 
efficacy of microinjections using CRISPR, we used a known genomic sequence to design a 
gRNA targeting the spadetail gene (Supplementary Table 1). Spadetail gRNA and Cas9 
mRNA were co-injected into single cell zebrafish embryos at a range of different 
concentrations (Supplementary Table 2). After allowing embryos to reach approximately 24 
hpf, the number of live embryos was counted and recorded. Living embryos were examined 
for the spadetail phenotype (Burger et al., 2014). Although different concentrations of gRNA 
and Cas9 mRNA were injected into the different clutches, no embryos displaying the 
spadetail phenotype when examined.  
Due to the absence of the spadetail phenotype after our initial test, we co-injected the 
spadetail gRNA and Cas9 protein at a variety of concentrations (Table 4). At approximately 
24 hpf, we recorded the number of living embryos and examined them for the spadetail 
phenotype (Figure 9F). All clutches contained embryos displaying the spadetail phenotype 
(Table 4). Embryos that were injected with 50 pg/nl of gRNA and 250 pg/nl of Cas9 protein 
(n= 195) showed the highest mutation rate (87.2%). 
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To further test the efficacy of Cas9 mRNA versus commercially obtained Cas9 
protein in the CRISPR/Cas9 system, we used a second known genomic sequence to design a 
gRNA targeting the golden pigmentation gene (Supplementary Table 1). Golden gRNA and 
Cas9 protein were co-injected into single cell embryos at varying concentrations (Table 5). 
Between 36 and 48 hpf, embryos were examined for hypopigmentation in skin melanophores 
and retinal pigment epithelium (RPE) (Fig. 9B, D). All clutches contained embryos 
displaying hypopigmentation (Table 5). Again, embryos that were injected 50 pg/nl of gRNA 
and 250 pg/nl of Cas9 protein (n= 287) showed the highest mutation rate (82.0%). The 
similar results in terms of efficacy observed using gRNAs targeting the tbx16 and golden 
genes suggested that the coinjection of 50pg/nl gRNA and 250pg/nl of commercially 
obtained Cas9 protein represented an optimal condition for subsequent experiments.  
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Figure 9: Mutant phenotypes in CRISPR injected embryos. (A-B’) Mutagenesis of 
golden (gol) pigmentation gene encoding slc24a5 (A, A’) wildtype uninjected control (B, B’) 
targeting golden with Cas9 protein generates a phenotype displaying mosaicism within the 
pigmented cells (C-D) Mutagenesis of tbx16 generating the spadetail phenotype (C) wildtype 
uninjected control (D) targeting tbx16 with Cas9 protein generates a phenotype displaying a 
broad posterior tail (E) Observed mutagenesis rates of golden and spadetail when injecting 
50 pg/nl of gRNA and 250 pg/nl of Cas9 protein into single cell embryos. All embryos are 
positioned in the lateralorientation and so that the anterior is to the left. 
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Table 4: Embryos Injected with Spadetail gRNA + Cas9 Protein    
Concentration  
gRNA/ Cas9 (pg/nl) 
 
100/250 
     
50/250 
 
25/250 
 
12.5/250 
Number injected 73 195 104 112 
Number alive  36 164 86 84 
Number w/ phenotype 8 143 63 39 
% successfully targeted 22.2% 87.2% 73.3% 46.4% 
 
Table 5: Embryos Injected with Golden gRNA + Cas9 Protein 
Concentration  
gRNA/ Cas9 (pg/nl) 
 
50/250 
 
25/250 
Number injected 287 154 
Number alive  245 123 
Number w/ phenotype 201 79 
% successfully targeted 82.0% 74.2% 
 
Dr-m2de1 gRNA Design  
 After observing high efficiency rates using CRISPR/Cas9 with both the spadetail and golden 
gRNAs, we moved to designing gRNAs to excise the m2de1 sequence from the zebrafish 
genome. Originally, we hoped to excise m2de1 in its entirety. Using CRISPRscan, a novel 
scoring algorithm developed by the Giraldez Lab at Yale University, we were able to identify 
potential gRNAs upstream and downstream of m2de1. Upstream of the element, there were 
no potential gRNAs with high efficacy scores and no off-target effects. However, we selected 
the upstream gRNA with the lowest off-target score and selected a downstream gRNA with a 
high efficacy score and no off-target effects. These two gRNAs together would lead to the 
deletion of approximately 1,229 basepair region of the genome that would include the entire 
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m2de1 sequence. After selecting the best possible gRNAs as indicated by CRISPRscan, 
embryos were injected with the CRISPR/Cas9 system and each of the gRNAs (Figure 10). 
Embryos that were injected in this manner consistently died at approximately 24hfp. This 
experiment was repeated four times (Table 6).  
Table 6: The number of embryos injected with the original m2de1 gRNAs during each 
of the four trials of the original m2de1 CRISPR injections.  
Trial # 1 2 3 4 
Concentration  
upstream gRNA/ 
downstream gRNA/ 
Cas9 (pg/nl) 
 
50/50/250 
 
50/50/250 
 
50/50/250 
 
50/50/250 
Number injected 78 69 112 101 
Number alive at ~24 hpf  14 11 17 9 
Number dead at ~ 24 hpf 64 58 95 92 
% Dead at ~24 hpf 82.1% 84.1% 84.8% 91.1% 
*The number of alive and dead embryos after approximately 24 hpf and finally the 
percentage of injected embryos that were dead by 24 hpf are also shown. 
 
To determine whether one or both of the gRNAs was responsible for the lethal 
phenotype, embryos were injected with either 50 pg/nl of the upstream gRNA and 250 pg/nl 
of the Cas9 protein or 50pg/nl of the downstream gRNA and250 pg/nl of the Cas9 protein. 
After injections, embryos that had been injected with the downstream gRNA and Cas9 
developed normally; however, embryos injected with the upstream gRNA and Cas9 died 
approximately 24 hpf. Due to the lethality generated by the upstream gRNA, gRNAs were 
redesigned.  
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gcatccactgcattaaacatatgctggaatagttggcggttcattccgctgtggtgacccctgatcaataaagagactaagctgaggg
aaaatgaatgaatgaatgaaaaatctgtgtaatgctctgaacactaatttttaaattgtttttctagttaaattatttgtataattttgttgactgaa
ttaataaagtaaaagaaattagaaagctcattataaggccgtgcatgttgagggtcgattgttgttaaaaaaaacaacaatacta
ctaataataatgaatgtcagcggttacggccactgacactgatgagctctggagtgtgtttgttaattaaagcccttctcggtgt
ggttataatcataagacagcgccgcgtgaacaacgtcgtatatcaaacttcacgatgcgacgccggctgataatgcgccgcc
gctgctaaagctgattttccatgatgaatctgagagcatataaattggctaatatctaaaaacatttacagacagtgcaggaac
cgagtgtttgcggccgtgatggatgaggctgttagatgctagaggacagatccgcaaatctctgccgctgcacagaccctgca
cgcagctacagatttactcctttaaacccgacctcctgtgtgtgtgtgtgagtttgtgtgagagagttagtgttagtgtgtgtgtattaa
agtgagtttaaatatgtttatatatgtgtgcataaatgtgtgtatatgtatatacacacatatacacatacacacacatatataaacatatacac
atataaacatacacacacatatataaacacatatacacacnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnntatatatatatatatatatatat
atatatatatatatatatatatatatatatatatatatatgtatatgtgtgtgtgtgtgtattttgtgagtgttatatctggagctctctcagcaaggt
tagtggggcagaactgatcttactctgtctgacagcagtgttgcggctcggtccgttatgcacatgtgtgtgtgagagctccacaactcc
acgctagtaattagtaaacttgtcaagatgctgcttcgctcaccgcctcccgcagctgctaatgaagagtgtgtgtgtcaggatttacagc
agaccgacgcgctgcacagaactccgcacaacacacttttctgtctcg 
Figure 10: Genomic DNA sequence located on chromosome 17 of zebrafish displaying 
the entire m2de1 sequence as well as upstream and downstream sequences. The bold and 
underlined sequences represent the DNA sequences that were originally selected to be 
targeted by the gRNA/ Cas9 complex to excise m2de1, which is indicated by the bold 
sequence. The first target DNA sequence is the complement of the actual sequence 
recognized by the gRNA.  
 
When attempting to redesign gRNAs to excise m2de1, there were no gRNAs with 
high efficacy scores and low off-target effects upstream of the element, as described on page 
61. Rather than selecting another upstream gRNA with potential off-target effects, we 
decided to aim to knockout a portion of m2de1, rather than the entire element. To determine 
whether or not the Dr-m2de1 sequence contained any potential gRNA sequences within the 
element, the element was screened for potential gRNAs using CRISPRscan. Within this 
region, only two potential gRNAs (Fig. 11) with no off-target effects were identified. These 
two gRNAs are separated by 42 basepairs (Fig. 11).  
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GCTCATTATAAGGCCGTGCATGTTGAGGGTCGATTGTTGTTAAAAAAAACAACAATACT
ACTAATAATAATGAATGTCAGCGGTTACGGCCACTGACACTGATGAGCTCTGGAGTGTG
TTTGTTAATTAAAGCCCTTCTCGGTGTGGTTATAATCATAAGACAGCGCCGCGTGAACAA
CGTCGTATATCAAACTTCACGATGCGACGCCGGCTGATAATGCGCCGCCGCTGCTAAAG
CTGATTTTCCATGATGAATCTGAGAGCATATAAATTGGCTAATATCTAAAAACATTTACA
GACAGTGCAGGAACCGAGTGTTTGCGGCCGTGATGGATGAGGCTGTTAGATGCTAGA
GGACAGATCCGCAAATCTCTGCCGCTGCACAGAGCCCTGCACGCAGCTACAGATTTAC
TCCTTTAAACCCGACCTCCTGTGTGTGTGTGTGAGTTTG 
 
Figure 11: Genomic DNA sequence located on chromosome 17 of zebrafish displaying 
the entire m2de1 sequence and gRNAs targets within the element. The entire sequence 
represents the m2de1 element while the bold sequences represent the target DNA sequence 
for gRNAs used to direct the Cas9 enzyme to excise a portion of m2de1. The protospacer 
adjacent motifs (PAMs) are shown in red. The second target DNA sequence is the 
complement, as the gRNA recognizes the 3’ strand of DNA. The region to be excised is 
underlined. 
 
Bioinformatical Analysis of Transcription Factor Binding Sites 
Since I was unable to excise the entire m2de1 sequence from the zebrafish genome, I 
wanted to ensure that I was excising an important part of the element as shown in figure 11. 
By taking the sequence in between the two gRNAs (Fig. 11) and entering it into the Patch 1.0 
database on gene-regulation.com, we were able to determine that there were indeed 
transcription factor binding sites between the two gRNAs. Predicted transcription factor 
binding sites include HOXA1/B1, Pbx-1a/1b, PKNOX1, Meis-1a/1b and GATA1 (Fig. 12). 
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Figure 12: Schematic of double stranded DNA containing the 82 basepairs that will be 
excised via m2de1 CRISPR injections. Patch1.0 was used to predict transcription factor 
binding sites. The transcription factor is shown either below or above the sequence 
depending on which strand of the double stranded DNA the factor is predicted to bind to. 
Transcription factors are color coordinated and are listed below the schematic.    
Dr-m2de1 knockout using CRISPR 
 After confirming that there were transcription factor binding sites located between the 2 
target DNA sequences shown in Figure 11/12, the gRNA sequences were transcribed and 
m2de1 CRISPR injections were performed on single cell zebrafish embryos. After injections, 
in order to  confirm that a portion of m2de1 was excised from the genome after CRISPR 
injections, genomic DNA was isolated from m2de1 CRISPR injected embryos. These 
embryos were randomly divided into 2 tubes for DNA extraction. This DNA was then used 
as a template for PCR in order to amplify m2de1. Samples from the PCR were run on an 
agarose gel (Fig. 13). Lane A contains a 100 basepair ladder, wildtype DNA was used as a 
control in Lane B, while Lanes C and D contained different samples of template DNA from 
injected embryos. Lanes B-D all displayed a band at approximately 450 basepairs, the size of 
the fully intact m2de1 element. However, Lane C also contained a lower molecular weight 
67 
 
band at approximately 350 basepairs (Fig. 13). This second band in Lane C indicates that 
some of the injected embryos were indeed transgenic and that the 82 basepairs between the 
gRNAs in m2de1 were likely removed.  
 
Figure 13: Agarose gel showing m2de1 partial knockout. Lane A contains a 100bp ladder. 
Lane B contains a positive control reaction using wildtype DNA. Lanes C and D contain the 
experimental reactions containing DNA extracted from m2de1 CRISPR injected embryos. 
Lanes C and D contain the same ~450 bp band as seen in wildtype. However, Lane C also 
contains a slightly lower molecular weight band at ~360 bp. This suggests that the knockout 
was at least partially successful in some of the injected embryos. 
After confirming that m2de1 CRISPR injections were at least somewhat successful 
by observing a PCR product consistent in length to that of the element missing the region 
excised in Figure 13, Lane C, whole mount in situ hybridization was performed in order to 
identify any potential differences in expression patterns in wildtype embryos verses 
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knockouts. m2de1 CRISPR injected embryos were fixed at 48 hpf in order to  examine 
expression of meis2a and zgc:154061. Embryos were fixed at 48 hpf due to the presence of 
the m2de1 element directing expression of eGFP beginning at 48 hpf. In wildtype embryos, 
meis2a expression is observed in the forebrain, optic tectum, cerebellum and 
rhombencephalon (Figure 14A). In embryos that had  been injected with the m2de1 CRISPR 
system, meis2a expression was observed faintly in the forebrain and optic tectum; however, 
expression in the cerebellum and rhombencephalon was not observed (Figure 14B). There 
was no observable difference in expression patterns of zgc:154061 in CRISPR injected 
embryos when compared to wildtype (data not shown). The number of injected embryos 
displaying an altered expression pattern is shown in Table 7. 
 
Figure 14: Whole mount in situ hybridization for meis2a on wildtype and partial 
knockout embryos. At 48 hpf, (A) wildtype embryos displayed meis2a expression in the 
forebrain (red arrow), optic tectum (blue arrow), cerebellum (black arrow) and 
rhombencephalon (orange arrow) (panel A was taken from Figure 7) while (B) m2de1 
CRISPR injected embryos displayed mild meis2a expression in the forebrain (red arrow) and 
optic tectum (blue arrow) but no expression is observed in the cerebellum or 
rhombencephalon. While these in situs were not developed at the same time, the same probe 
was used for both embryos. All embryos are positioned in the lateral orientation with the 
anterior to the left.   
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Table 7: The concentration of gRNAs and Cas9 protein injected into each embryo for 
m2de1 CRISPR injections.  
Embryos injected with m2de1 CRISPR system Trial 1 
Concentration  
upstream gRNA/ downstream gRNA/ Cas9 (pg/nl) 
 
50/50/2
50 
Number injected 89 
Number dead at ~48 hpf  51 
% Dead at ~48 hpf 42.7% 
Number alive/ fixed at ~48 hpf 51 
Number of fixed embryos displaying WT meis2a expression pattern 42 
Number of fixed embryos displaying altered meis2a expression pattern 9 
* The number of injected embryos is also shown, as well as a breakdown of dead/ alive 
embryos and the number of embryos showing altered expression patterns as compared to 
wildtype. 
 
After observing a different expression pattern in embryos that had previously been 
injected with the m2de1 CRISPR system, DNA was extracted from these embryos in order to 
confirm deletion. Individual embryos that displayed a different expression pattern as 
compared to wildtype embryos were placed into individual tubes for DNA extraction. This 
DNA was then used as a template for PCR in order to amplify m2de1. Samples from the PCR 
were run on an agarose gel (Fig. 15). Lane A contains a 100 basepair ladder, while wildtype 
DNA was used as a control in Lane B. Lanes C contains DNA from embryos that were 
injected with the CRISPR/Cas9 system but show no difference in meis2a expression pattern 
when compared to wildtype (data not shown). Lastly, Lane D contains the DNA extracted 
from the mutant embryo in Figure 14B. While Lanes B-D all contain a band at approximately 
450 basepairs, indicative of the unmutated m2de1 element, Lane D also contains a lower 
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molecular weight band around 350 basepairs indicating that m2de1 was partially excised on 
one allele through CRISPR injections.  
 
Figure 15: Agarose gel showing m2de1 partial knockout. Lane A contains a 100bp ladder. 
Lane B contains a positive control reaction using wildtype DNA. Lanes C contains extracted 
DNA from CRISPR injected embryos showing the same meis2a expression as wildtype 
embryos. Lane D contains the DNA extracted from an m2de1 CRISPR injected embryo that 
displayed an altered expression pattern of meis2a. Lanes C and D contain the same ~450 bp 
band as seen in wildtype. Lane D also contains a slightly lower molecular weight band at 
~360 bp.  
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Discussion  
By examining developmental genes for their specific function and expression 
patterns, insight can be gained into the regulation of patterning, morphogenesis, 
differentiation and growth. While the expression patterns of the Meis genes are fairly well 
characterized, the mechanisms that direct the Meis genes expression at the correct time and to 
the correct place during development are largely unknown. Previously, the Zerucha lab has 
identified four highly conserved noncoding elements associated with the vertebrate Meis2 
gene and named them m2de1-4 (for Meis2 downstream element). The four putative 
enhancers are present in humans, chicken, mice and other tetrapods and in each organism, 
they are found downstream of Meis2. However, in zebrafish, only one of these presumed 
enhancers has been identified. Interestingly, these elements are found within the introns of an 
adjacent gene, zgc:154061 in zebrafish, whose orthologs are always found in an inverted 
convergently transcribed orientation directly downstream of Meis2 in vertebrates. I have 
observed overlaps in the expression patterns of meis2a and zgc:154061 as well as the 
expression of a reporter transgene directed by m2de1 in zebrafish.  I propose that the 
genomic organization of these two genes has been evolutionarily conserved due to the 
sharing of cis-regulatory elements. In this study, I have used the CRISPR/Cas9 system to 
excise a portion of the m2de1 element in zebrafish to determine whether or not meis2a or 
zgc:154061 expression is affected.  
Generation of a stable transgenic line expressing eGFP 
Our lab has previously shown that m2de1 directs eGFP expression to the forebrain, 
midbrain and hindbrain of zebrafish embryos at 48 and 54 hpf (Barrett, C., 2013; Ferrara, T., 
2015). The element has shown to direct expression to the same areas whether in forward or 
reverse orientation (Barrett, C., 2013). This is expected because the proteins interacting with 
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m2de1 should be able to recognize the DNA sequence regardless of forward or reverse 
orientation. While the expression directed by m2de1 has been observed in primary injected 
embryos multiple times, a stable transgenic line has yet to be generated. A stable line would 
eliminate mosaicism, a common issue in trying to interpret data form primary transgenic 
organisms. A homozygous line would allow us to visualize the full pattern of expression 
driven by the m2de1 element, especially expression that has been observed only faintly 
previously, such around the eye (Ferrara, 2015). Further, a stable transgenic line would allow 
us to more specifically determine where the element directs localized expression. To date, we 
are able to observe relative expression patterns, specifically around the head. However, the 
zebrafish head contains many overlapping sections and a stable transgenic line would allow 
us to differentiate between the overlapping segments. Currently, pDr m2de1-F-cfos-EGFP 
injected embryos are being raised in hopes to breed the primary injected fish to generate a 
stable line. 
Whole mount in situ hybridization 
Expression of meis2a has previously been shown to be expressed in the forebrain, 
hindbrain and neural plate in zebrafish at the 2-somite stage. At the 5-somite stage, meis2a 
expression in the hindbrain expands anteriorly and by the 10-somite stage, meis2a is 
expressed in the eyes, the forebrain, the developing tectum and within the neural rod (Bessa 
et al., 2008; Thisse and Thisse, 2005; Waskiewicz et al., 2001). At later stages during 
development, meis2a expression has been observed in the forebrain, retina, eye, midbrain, 
hindbrain, spinal cord and neural tube at 24 hpf. At 48 hpf, the meis2a expression is no 
longer observed in the neural tube but is still observed in the forebrain, eye, retina, midbrain, 
hindbrain and spinal cord, as well as, the optic tectum and tegmentum (Carpenter et al., 2016; 
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Thisse and Thisse, 2005). In this study, whole mount in situ hybridization was performed in 
order to visualize meis2a expression at later timepoints during development. At 24 and 48 
hpf, meis2a expression was observed in the forebrain, which correlates with the expression 
observed by Carpenter et al. and Thisse and Thisse. Additionally, meis2a was observed in 
optic tectum, cerebellum and rhombencephalon at both 24 and 48 hpf. However, meis2a was 
not observed in the spinal cord or neural tube as observed previously (Carpenter et al., 2016; 
Thisse and Thisse, 2005). The meis2a expression in the spinal cord and neural tube observed 
previously by Carpenter et al. and Thisse and Thisse was faint. In this experiment, we 
developed embryos for in situ hybridization for a shorter period of time in order to eliminate 
any background color. Due to this shortened period of color development, we most likely 
quenched our reactions before the expression in the spinal cord and neural tube became 
visible.   
At 54 hpf, meis2a was observed in the forebrain, retina, optic tectum and cerebellum. 
At 60 hpf, the retina expression disappeared and expression was still observed in the 
forebrain, optic tectum and cerebellum. At 66 hpf, the optic tectum expression was no longer 
observed; however, at both 66 and 72 hpf, meis2a was observed in the forebrain and 
cerebellum. Our results coincide with previously published data as expression of meis2a 
becomes more anteriorly restricted as development progresses (Bessa et al., 2008; Carpenter 
et al., 2016; Thisse and Thisse, 2005; Waskiewicz et al., 2001).  
 Previously, the Zerucha lab identified a conserved gene, zgc:154061 in zebrafish, that is 
located downstream of meis2a. Whole mount in situ hybridization was performed in order to 
visualize spatial and temporal expression of zgc:154061. Analysis revealed transcripts of the 
gene were present as early as the zygotic period (0-0.75 hpf). Transcripts were also observed 
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during the cleavage (0.75-2.25 hpf) and blastula (2.25-5.25) periods. The zygotic genome 
does not become active until the midblastula transitition (around 2.75 hpf), therefore, the 
observation of transcripts of zgc:154061 during the zygote, cleavage and blastula periods 
indicates that the gene is expressed maternally. Around 12 hpf, the expression of zgc:154061 
was observed to be anteriorly restricted, with expression appearing in the developing neural 
tube around the retina, forebrain, olfactory region and the tectum of the midbrain. At 24 hpf, 
expression was observed to be restricted to the neural tube and eye, while at 48 hpf 
expression was observed in the retina, forebrain, olfactory region and the tectum of the 
midbrain. At 48 hpf, expression of zgc:154061 gradually begins to decrease, so much that 
localized expression becomes unobservable (Carpenter et al., 2016). In this study, whole 
mount in situ hybridization was performed in order to visualize zgc:154061 expression at 
later timepoints during development. At 24 hpf, zgc:154061 expression was observed in the 
developing neural tube around the forebrain, optic tectum, cerebellum and rhombencephalon 
which correlates with the expression observed by Carpenter et al. in 2016; however, the faint 
expression observed by Carpenter et al. in the developing eye at 24 hpf was not observed in 
this study. In this experiment, in order to eliminate any background color, we developed in 
situs for a relatively short period of time and we most likely quenched our reactions before 
the expression in the eye became visible.  At 48 hpf, expression does seem to decrease as 
suggested by Carpenter et al. However, in this study, whole mount in situ hybridization was 
overdeveloped in order to attempt to identify areas of expression. Between 48 and 72 hpf, 
localized expression was not identified; however, relative expression was identified around 
the retina and forebrain at 48, 54, 60, 66 and 72 hours. Additionally, zgc:154061 was 
observed in the cerebellum at 54 hpf.  
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The expression of zgc:154061 is anteriorly restricted between 48 and 72 hpf, which is 
similar to meis2a expression, which is also restricted anteriorly during these timepoints. Both 
meis2a and zgc:154061 are observed in the developing neural tube, specifically around the 
forebrain between 24 hpf until 72 hpf. Further, Meis2 is known to play a role in the 
development of the eye (Zhang et al., 2002) and we observed zgc:154061 expression around 
the eye between 48 and 72 hpf. If meis2a and zgc:154061 are sharing cis-regulatory elements 
as we predict, the overlapping expression patterns that we observe would be expected. While 
each gene normally has its own set of cis-regulatory elements, elements commonly direct the 
expression of multiple genes (Gould et el., 1997; Zerucha et al., 2000). 
CRISPR injections using a positive control 
Before beginning CRISPR injections to excise a portion of m2de1, positive control 
CRISPR injections were completed. In accordance to Talbot and Amacher (2014) 40ng/μl of 
spadetail gRNA and 80ng/μl of Cas9 mRNA were injected into single cell zebrafish 
embryos. At 24 hpf, the spadetail phenotype was not observed. In 2013, Hwang et al. 
generated several gRNAs that targeted the fh gene of zebrafish. By co-injecting the gRNAs 
with Cas9 mRNA, mutation rates ranged from 10-52.7%. The highest average mutation rate 
occurred with an injection concentration containing 12.5ng/uL gRNA and 300ng/uL Cas9 
mRNA. Using this information, we completed a second round of injections with 12.5ng/uL 
spadetail gRNA and 300ng/uL Cas9 mRNA into single cell zebrafish embryos. Still, no 
phenotype was observed. The concentration of gRNA and Cas9 mRNA was altered two 
additional times (Supplementary Table 2) in order to observe the spadetail phenotype. 
Concentrations came from unpublished data and personal communications. However, after 
each round of subsequent injections, the phenotype was never observed (Supplementary 
76 
 
Table 2). Rather than continuing to troubleshoot CRISPR injections, EnGen® Cas9 NLS 
(NEB Mo646T) was commercially obtained for CRISPR injections.  
In accordance with the zebrafish CRISPR injection protocol by Jeffrey Essner (2016), 
50ng/ul gRNA and 250 ng/μl Cas9 protein was used for CRISPR injections. At 
approximately 24 hpf, the spadetail phenotype was observed. The concentration of gRNA 
was both increased and decreased in subsequent rounds of injections to determine the most 
efficient concentration. These concentrations were also tested with golden injections. For 
each positive control, 50ng/μl gRNA and 250ng/μl Cas9 protein showed to be most efficient.  
In 2016, in order to compare the efficiency of in vitro assembled Cas9-sgRNA 
ribonucleoprotein complexes, Burger et al. assembled and injected Cas9-sg RNA RNPs into 
single cells zebrafish embryos. Burger et al. targeted gol and compared their results to those 
results obtained by Jao et al. 2013. Jao et al. injected single cell embryos with 50pg of gol 
gRNA and 150pg of nls-zCas9-nls RNA. At 48 hpf, mosaic hypopigmentation was observed 
in skin melanophores and RPE in 94% of the injected embryos, while mutagenesis rates 
ranged from 78-98%, indicating that most cells contained bi-allelic mutations (Jao et al., 
2013). In comparison, when gol was targeted with Cas9-sgRNA RNPs, nearly 80% of 
successfully injected embryo displayed strong mutant phenotypes. The remaining 20% of 
embryos displayed different degrees of the mutant phenotype (Burger et al., 2016). 
Furthermore, the injected embryos maintained the mutant phenotype as compared to 
morpholino knockdowns, which only maintain the gene knockdown for a few days (Bill et 
al., 2009; Burger et al., 2016). When the gol mutants were grown to adulthood, the mutant 
phenotype was preserved. The fish were then in-crossed resulting in the F1 offspring 
displaying complete mutant phenotypes, showing that when the gol loci was targeted with 
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Cas9-sgRNA RNPs, the germline of injected embryos was mutated (Burger et al., 2016). As 
mentioned previously, in addition to targeting golden, Burger et al. also used RNPs to 
recapitulate loss of function phenotypes, like spadetail. Using RNPs to target spt, more than 
60% of all embryos injected displayed a strong phenotype while almost 20% displayed a 
mild or partial phenotype. Analysis via MiSeq and CrispRVariants revealed that RNPs allow 
for efficient bi-allelic mutagenesis for both golden and spadetail (Burger et al., 2016). 
Burger et al. reported the most efficient concentration of Cas9 protein to be 831ng/μl, 
while the optimal gRNA concentration varied depending on the DNA sequence and the 
molar mass. Burger et al. determined gRNA concentration using a free online calculator, 
CrispantCal, available at http://lmweber.github.io/CrispantCal/. Contrary to these results, our 
results showed the highest efficacy of all gRNAs at a concentration of 50ng/ul gRNA. While 
we did not test different concentrations of Cas9 protein, we showed that 250ng/ul Cas9 was 
efficient. Burger et al. displayed 80% strong mutant phenotypes for gol injections, while the 
remaining 20% showed mild phenotypes. In our test, we saw 82% of embryos displaying the 
gol phenotype. Using spadetail, Burger et al. showed about 80% of injected embryos with the 
mutant phenotype while our results displayed 87.2% mutant phenotype. Although our Cas9 
protein differed from the protein utilized by Burger et al., our commercially obtained protein 
shows to be effective at a comparable rate, indicating this to be more efficient and cost 
effective than generating our own in vitro translated Cas9. 
In our original injections with Cas9 mRNA, we consistently observed no embryos 
displaying mutant phenotypes; therefore, we hypothesize that the integrity of the plasmid was 
compromised and are not taking our mutagenesis rates using Cas9 mRNA into consideration 
when comparing Cas9 mRNA and Cas9 protein. Using Cas9 mRNA, Jao et al. reported gol 
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injected embryos showed mutagenesis rates between 78-98%. Burger et al. reported 100% of 
gol injected embryos showed a mutant phenotype, 80% with a strong phenotype and 20% 
with a weak phenotype, when using in vitro assembled Cas9. Finally, our results show 82.0% 
mutant phenotype using Cas9 protein. Combined, these results suggest that protein is not 
necessarily more efficient than Cas9 mRNA; however, in vitro assembled Cas9 provides an 
effective reagent that can be replicated for direct and measurable knockout and loss-of-
function studies.  
Identifying CRISPR Target 
Originally, in order to excise m2de1 in its entirety, we examined the zebrafish 
genome upstream and downstream of m2de1 for potential gRNAs. We were aiming to keep 
the knockout under 1500 basepairs in hopes of preventing NHEJ from occurring between cut 
sites. Using CRISPRscan to identify potential gRNAs, there were no upstream gRNAs within 
our region with low off-target scores. High off-target scores indicated that our chance of 
knocking out m2de1 in its entirety could be compromised due to the possibility of Cas9 
cutting at these off-target locations rather than upstream of m2de1. Although the upstream 
gRNA scores predicted off-target effects, we chose the gRNA in the area with the lowest off-
target score. Downstream of the element, we chose a gRNA with no off-target effects. Upon 
injections with these gRNAs and Cas9, we observed that the embryos consistently died by 24 
hpf. Upon further experimentation, we observed that the upstream gRNA and Cas9 generated 
the same lethal phenotype, while the downstream gRNA and Cas9 did not generate a lethal 
phenotype. We hypothesized that the high off-target score associated with the upstream 
gRNA could be the reason we were observing the lethal phenotype. If the upstream gRNA 
was directing Cas9 to a location rather than upstream of m2de1, there is a chance we were 
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knocking out some other unknown but necessary sequence within the genome that caused 
lethality.  
Due to the observed lethal phenotype generated by the upstream gRNA, gRNAs were 
redesigned. We had established that there were no upstream gRNAs within our region with 
no off-target effects. Because of this, rather than excising m2de1 in its entirety, we aimed to 
excise a portion of m2de1. In order to excise a portion of m2de1, we looked within the 
element for potential gRNAs. Two gRNAs with zero off-target effects within m2de1 were 
identified. To determine how necessary the sequence between these gRNAs was, the 
sequence was examined for putative transcription factor binding sites. The search revealed 
numerous deuterostome putative binding sites between the potential gRNAs. While Figure 12 
shows putative transcription factor binding sites for various deuterostomes rather than only 
zebrafish, these sites are relevant because possible homologous transcription factors could 
bind to the zebrafish sequence. Particularly of interest, the sequence contains predicted 
binding sites for homeodomain proteins HOX, Pbx and Meis. As mentioned previously, Meis 
and Pbx commonly interact with Hox proteins in binding DNA and controlling gene 
transcription (Choe et al., 2014). Not only do these proteins bind to DNA, they also have the 
ability to interact with one another, binding through structures within their N-terminal and C-
terminal domains (Chang et al.,1997). It is interesting that putative binding sites for each of 
these three proteins were identified within the 82 basepair sequence between gRNAs. This 
suggests that this portion of m2de1 may contain binding sites for a combination of important 
regulatory proteins. The presence of a Meis recognition sequence also suggest the possibility 
of auto- or cross-regulatory interactions controlling Meis2 expression. 
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Further, the sequence contains a putative GATA1 binding site. Previously, GATA1 
has been shown to encode a critical hematopoietic transcription factor (Valverde-Garduno et 
al., 2004). This is of particular interest considering both Meis and C15ORF41 (the human 
zgc:154061 ortholog) have been linked to blood. Meis genes were first discovered in a study 
of mouse myeloid ecotropic leukemia virus and an overexpression of Meis1 causes blood 
cancer in humans and mice (Hisa et al., 2004, Moskow et al., 1995). Additionally, 
C15ORF41 has been shown to play a role in erythropoiesis (Babbs et al., 2013). After the 
bioinformatical analysis of the sequence between the gRNAs identified in Figure 11, it was 
decided that excising this portion of m2de1 could indeed affect the element’s potential ability 
to act as a cis-regulatory element for meis2a and/or zgc:154061. 
m2de1 knockout, in situ hybridization and DNA extraction 
The second band in Figure 13, Lane C indicated that some of the injected embryos 
were indeed transgenic and that a portion of the sequence between the gRNAs in m2de1 was 
excised. Because DNA was extracted from multiple embryos, it is impossible to determine 
whether the portion of m2de1 was excised from both alleles from any of the embryos, as the 
second band could indicate heterozygotic embryos. However, observing that the m2de1 
CRISPR injections were somewhat successful, injected embryos were fixed at approximately 
48 hpf. Embryos were fixed at 48 hpf because this is the earliest stage where m2de1 has been 
observed to direct the expression of eGFP. Whole mount in situ hybridization for both 
meis2a and zgc:154061 was completed. Upon examination, no difference in expression 
pattern was observed between wildtype embryos and CRISPR injected embryos for 
zgc:154061 (data not shown). However, this could be due to the already low levels of 
expression of zgc:154061 and the inability to distinguish any changes in expression to this 
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already low and difficult to visualize expression pattern in wildtype embryos. When 
observing meis2a expression for CRISPR injected embryos, 42 embryos did not display an 
altered expression pattern (data not shown). When DNA was extracted from these embryos 
and PCR was utilized to amplify m2de1, it was observed that these embryos only contained 
the wildtype m2de1 element. While 42 embryos did not show a difference in meis2a 
expression, 9 m2de1 CRISPR injected embryos showed a variation in meis2a expression 
verses the wildtype expression pattern (Figure 14) (Table 7). After these embryos were 
imaged, DNA was extracted and used to amplify the m2de1 element. After PCR 
amplification and gel electrophoresis, it was confirmed that the embryo pictured in Figure 
14B had a wildtype version of m2de1, as well as a version of m2de1 missing the described 
region.  
As mentioned previously, predicted transcription factor binding sites within the 
described area include HOXA1/B1 and Pbx-1a/1b. Hoxa1/b1 have been shown to play a role 
in hindbrain and craniofacial development. In mice, Hoxa1 is expressed in the forebrain and 
midbrain during embryonic development (McClintock et al., 2002; Shih et al., 2001). 
Further, Hoxa1 null mutants display reduced or absent rhombomeres-4 and 5, leading to 
defects in the hindbrain (Carpenter et al., 1993; Chisaka et al., 1992; Dolle et al., 1993; Mark 
et al., 1993). In Hoxb1 null mutants, the identity of r4 is altered and mutant mice fail to 
develop the somatic motor component of the VIIth (facial) nerve (Goddard et al., 1996; 
Studer et al., 1996). Similarly, Pbx1 is expressed in high levels in the developing rat brain 
(Roberts et al., 1995). PBX1 is also expressed abundantly in the human fetal brain, while 
PBX2 is expressed at lower levels in the human fetal brain (Monica et al., 1991). If the 
excised portion of m2de1 contains binding sites for Hox and Pbx proteins as predicted, this 
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could explain the lack of expression in the cerebellum and rhombencephalon of the mutant 
embryo. 
Further, there are also predicted transcription factor binding sites for Meis-1a/1b 
within the described region.  Murine Meis1 and Meis2 and human MEIS2 have an identical 
amino acid sequence within their homeodomains, resulting in human Meis2 binding to the 
same consensus DNA sequence as murine Meis1. This sequence has been identified as 5’-
TGACAG-3’ (Yang et al., 2000). Because these Meis proteins bind to identical sequences, it 
is possible that meis2a, as well as meis1a/1b, could contain a binding site within the 
described portion of m2de1. Given this information, it is possible that Meis proteins auto- 
and/or cross-regulate Meis genes. If m2de1 is directing meis2a expression, knocking out a 
Meis binding site within the element could alter when, where and how much meis2a is 
expressed which would also help to explain the altered expression pattern observed in 
Figure14B. Together, the role of Hox and Pbx in the developing brain, as well as the 
possibility of auto- and/or cross-regulation between Meis proteins, could help to explain why 
we see an altered expression pattern of meis2a in mutant embryos. If m2de1 is directing the 
expression of meis2a, removing putative binding sites for transcription factors that play a role 
in brain and craniofacial development could affect when and where meis2a is expressed.  
In the future, sequencing can be completed in order to confirm exactly which portion 
of m2de1 has been excised out of different fish and this could help to explain the mosaicism 
observed and help to understand which putative binding sites might be crucial. It would also 
be of interest to study the interactions between the DNA in the knockout region and specific 
proteins using chromatin immunoprecipitation (ChIP) in order to understand exactly which 
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transcription factors are playing a role, whereas now we are basing our information off of 
putative transcription factor binding sites. 
It was interesting that individual knockout embryos contained a wildtype and mutant 
version of m2de1. In both of our positive control CRISPR injections, we observed biallelic 
knockouts as both gol and spadetail phenotypes are only observed in null mutants (Burger et 
al., 2016; Jao et al., 2013). However, a possible explanation is that m2de1 null embryos 
display a lethal phenotype. We observed that 42.7% of m2de1 CRISPR injected embryos 
died before reaching 48 hpf (Table 7). It is possible that the high death rate was due to 
biallelic disruption of m2de1 in some of these embryos. When DNA was extracted from 
these m2de1 CRISPR injected embryos and used as a template to amplify the m2de1 
element, the agarose gel displayed bands indicative of both wildtype and mutant m2de1 (data 
not shown). Because the template DNA came from a combination of embryos, it is 
impossible to tell whether any of these dead embryos were m2de1 null mutants; however, the 
mutated version of m2de1 was present in a portion of the embryos and it will be interesting 
in the future to determine the differences, if any, between heterozygotic and null mutants.  
While heterozygotic and homozygotic mutants could display different phenotypes, 
there are other variables that could affect m2de1 CRISPR knockouts as well. The 
protospacer-adjacent motif (PAM) interacting domain is responsible for initiating binding of 
target DNA. The arginine-rich bridge helix contacts between 8 to 10 nucleotides on the 3’ 
end of the target DNA and initiates cleavage (Figure 3) (Jinek et al., 2014; Nishimasu et al., 
2014). Further, NHEJ repair mechanisms leads to imperfect or frameshift repairs. This type 
of repair is thought to introduce insertions and deletions of random lengths, normally 
between 1-18 basepairs, which can lead to mosaicism in CRISPR-modified organisms 
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(Maruyama et al., 2015). Together, the variation in where Cas9 cleaves the DNA and the 
length of insertions and deletions due to NHEJ, CRISPR injected embryos can contain a wide 
variety of mosaicism. This could mean that while some embryos have 70-100 basepairs of 
m2de1 excised from their genome, others may only contain a 30-40 basepair excision. This 
could greatly affect whether or not the injections are lethal while also affecting the 
expression pattern of meis2a. For example, the putative transcription factor binding sites in 
the outer most 10-15 nucleotides may be excised in some embryos and not excised in other 
embryos. If these putative binding sites are crucial in directing meis2a expression, embryos 
with a larger portion of the sequence excised may die or display weak expression of meis2a 
while embryos with smaller knockout regions display a wildtype expression pattern. As 
mentioned previously, it will be important to sequence this genomic region where the 
excision occurs in order to confirm its absence. This will help to better understand the 
mosaicism that is observed in knockouts.   
 In conclusion, the data presented in this study shows expression of meis2a and 
zgc:154061 at older timepoints throughout development, as previous studies had only 
examined expression patterns up to 48 hpf (Bessa et al., 2008; Carpenter et al., 2016; Thisse 
and Thisse, 2005; Waskiewicz et al., 2001). The expression patterns of both genes show 
overlap between 48 and 72 hpf. Further, at 48 and 54 hpf, the expression of both genes 
overlaps with the expression directed by m2de1. When a portion of the m2de1 element that 
contains numerous putative binding sites is excised from the zebrafish genome, a difference 
in meis2a expression at 48 hpf is observed when compared to wildtype embryos. While a 
direct relationship between meis2a and m2de1 cannot yet be confirmed, we hope to raise a 
stable transgenic line of m2de1 knockouts in order to better understand the relationship 
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between m2de1and meis2a and zgc:154061. The work completed for this project assisted in 
further characterizing m2de1, a novel element hypothesized to be involved in the regulation 
of meis2a and zgc:154061 and their orthologs. 
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Supplementary Material 
Supplementary Table 1: Target sequence for Spadetail gRNA and Golden gRNA 
gRNA Target Sequence 
Spadetail 5’-GGGTGCAGGTACGTCCTGTA-3’ 
Golden  5’-GGTCTCTCGCAGGATGTTGC-3’ 
 
Supplementary Table 2: Embryos injected with Spadetail gRNA + Cas9 mRNA 
Concentration  
gRNA/ Cas9 (pg/nl) 
 
40/80 
 
25/100 
 
75/250 
 
12.5/300 
Number injected 112 75 467 523 
Number alive  78 59 309 298 
Number w/ phenotype 0 0 0 0 
% successfully targeted 0% 0% 0% 0% 
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